6,122 results on '"Chlamydia Infections diagnosis"'
Search Results
2. Epidemiology of Chlamydia trachomatis and Repeat Positivity Following Detection in New York State.
- Author
-
Currenti S, O'Grady T, Bomma S, Gurram N, Miranda W, and Hart-Malloy R
- Subjects
- Humans, Female, Male, New York epidemiology, Adolescent, Adult, Middle Aged, Young Adult, Logistic Models, Risk Factors, Chlamydia Infections epidemiology, Chlamydia Infections diagnosis, Chlamydia trachomatis isolation & purification
- Abstract
Background: In New York State, excluding New York City, chlamydia remains a persistent health concern. Our aim was to characterize chlamydia epidemiology and identify groups at higher risk of repeat positivity to inform targeted public health interventions., Methods: We analyzed demographic and clinical data of laboratory-confirmed chlamydia cases in New York State from 2015 to 2019. Repeat positivity was defined as a second positive chlamydia test within 31 to 365 days of the initial positive test. We compared characteristics of individuals with single and repeat positivity and evaluated associations with repeat positivity using multivariable logistic regression models., Results: During the study period, 176 273 individuals were diagnosed with chlamydia, with 17 253 experiencing repeat positivity. Repeat positivity was more common among individuals assigned female at birth. Key predictors of repeat positivity among females included non-Hispanic Black (adjusted odds ratio [aOR]: 1.33; 95% confidence interval [CI], 1.27-1.40) race/ethnicity, ages 13 to 19 (aOR: 1.62; 95% CI, 1.55-1.69), prior sexually transmitted infection (STI) diagnosis (aOR: 1.24; 95% CI, 1.18-1.31), symptomatic examination (aOR: 1.07; 95% CI, 1.02-1.13), and county/community (aOR: 1.10; 95% CI, 1.05-1.15) or private/public (aOR: 1.18; 95% CI, 1.11-1.25) provider. Among males, predictors included non-Hispanic Black (aOR: 1.57; 95% CI, 1.45-1.70) race/ethnicity, ages 13 to 19 (aOR: 1.27; 95% CI, 1.17-1.38), HIV coinfection (aOR: 1.30; 95% CI, 1.10-1.54), prior STI diagnosis (aOR: 1.31; 95% CI, 1.20-1.43), extragenital infection site (aOR: 2.59; 95% CI, 2.27-2.95), symptomatic examination (aOR: 1.21; 95% CI, 1.12-1.31), and county/community health (aOR: 1.09; 95% CI, 1.02-1.17) provider., Conclusions: Our findings provide valuable insights for sexual health interventions to prevent chlamydia transmission and recurrence. Prioritizing resources for prevention interventions and tailored sexual health promotion among non-Hispanic Black individuals is crucial. Additionally, targeted STI prevention efforts are needed for males who have sex with men and those initially diagnosed with extragenital infection. Research is warranted on STI prevention among people living with HIV or at high risk of HIV infection. Strengthening prevention strategies through Expedited Partner Therapy and sexual health education for individuals at risk of repeat positivity could enhance prevention efforts., Competing Interests: The authors declare there are no conflicts of interest., (Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
3. Impact of point-of-care gonorrhea and chlamydia testing in the emergency department on reducing overtreatment rates.
- Author
-
Feltes A, Combs J, Reynolds M, Conroy M, Lindsey S, Dick M, Li J, and Reichert E
- Subjects
- Humans, Female, Retrospective Studies, Male, Adult, Chlamydia trachomatis isolation & purification, Middle Aged, Neisseria gonorrhoeae isolation & purification, Emergency Service, Hospital, Chlamydia Infections diagnosis, Chlamydia Infections drug therapy, Gonorrhea diagnosis, Gonorrhea drug therapy, Medical Overuse prevention & control, Medical Overuse statistics & numerical data, Point-of-Care Testing
- Abstract
Background: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections continue to increase in the United States. Advancement in technology with point-of-care (POC) testing can improve the overall treatment of sexually transmitted infections (STI) in the emergency department (ED) by shortening the time to test result and administration of accurate treatment. The purpose of this study was to assess if the POC test reduced the rate of overtreatment for CT and/or NG compared to the standard-of-care (SOC) test., Methods: This retrospective cohort study included adult patients tested for CT and NG at two urban EDs between August 2020 and October 2022. This cohort excluded hospital admissions, elopement, pregnancy, rectal and oral samples, victims of sexual assault, and diagnoses for which antimicrobial treatment overlapped that of CT/NG. The primary outcome assessed overtreatment, defined as receiving treatment in the ED or a prescription prior to discharge for patients who tested negative for CT and/or NG. Secondary outcomes included undertreatment rates, overtreatment rates in select populations, test turnaround time, and ED length of stay (LOS)., Results: Of 327 patients screened, 97 patients were included in the SOC group and 100 in POC. Overtreatment for CT was provided in zero POC patients and 29 (29.9%) SOC patients (p < 0.001). NG was overtreated in 1 (1%) POC and 23 (23.7%) SOC (p < 0.001). POC was associated with undertreatment of CT and/or NG in two patients, compared to four patients tested with SOC. Overall, treatment was deemed inappropriate for 5 (5%) of those tested with POC, compared to 35 (36%) tested with SOC (p < 0.001). There was no difference in ED LOS (2.7 vs 3.01 h, p = 0.41)., Conclusions: POC testing facilitated the return of results prior to patients being discharged from the ED. Compared to standard testing, POC improved appropriateness of CT and NG treatment by reducing the rates of overtreatment., Competing Interests: Declaration of competing interest None of the authors included on this manuscript have any significant or potential conflicts of interest., (Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
4. Point-of-care STI testing in rural settings: A feasibility project.
- Author
-
Townsend H, Hobbs J, Kaylor S, Cody S, and Callihan M
- Subjects
- Humans, Alabama, Female, Sexually Transmitted Diseases diagnosis, Male, Rural Population, Adult, Health Services Accessibility, Mobile Health Units, Chlamydia Infections diagnosis, Rural Health Services, Point-of-Care Systems, Gonorrhea diagnosis, Feasibility Studies, Focus Groups, Point-of-Care Testing
- Abstract
Sexually transmitted infections (STIs) continue to be a health concern in the United States, particularly in rural settings. Point-of-care (POC) STI testing is useful in overcoming access barriers in these settings. The purpose of this project was to implement POC STI testing to increase access to care in rural settings and test the feasibility of this model. Six mobile health clinics were implemented by a nurse-led team in three rural communities in the Blackbelt region of Alabama utilizing the Binx IO® to test for chlamydia and gonorrhea. Mobile clinic volunteers participated in focus groups to determine provider satisfaction with clinic workflow. The mobile health clinics were a feasible way to increase access to STI testing in rural settings with reported provider and client satisfaction in work flow., (© 2024 Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
5. Impact of education and clinic site champion on extragenital testing for sexually transmitted infections.
- Author
-
Cunningham VC, Hurdelbrink J, Smith HL, Sittig KR, and Veach LA
- Subjects
- Humans, Female, Male, Adult, Chlamydia Infections diagnosis, Patient Education as Topic methods, United States, Specimen Handling methods, Rectum microbiology, Gonorrhea diagnosis, Ambulatory Care Facilities, Sexually Transmitted Diseases diagnosis, Neisseria gonorrhoeae isolation & purification, Chlamydia trachomatis isolation & purification
- Abstract
Background: Sexually transmitted infections (STIs) are on the rise in the United States. Infections at extragenital (EG) sites (throat or rectum) may serve as an overlooked reservoir for STIs. The aims of this project were to determine the proportion of patients receiving EG testing and to observe the impact of an educational intervention., Methods: Phase I included four urgent care clinics and baseline data for adults receiving STI testing ( Chlamydia trachomatis and Neisseria gonorrhoeae ). Clinics received access to an educational presentation regarding the importance of EG testing. Two of these clinics served as pilot sites for the implementation of self-collection kits. Phase II involved further expansion and utilization of clinic site champions., Results: Phase I baseline data indicated that less than 1% of samples from patients receiving STI testing were from EG sites. There was an increase in EG testing after the educational intervention and implementation of self-collection kits. A larger increase in EG testing was seen after utilization of a site champion in Phase II., Conclusion: EG infections serve as a potential source for STI transmission which makes multi-site testing necessary. Our interventions to improve EG testing were most effective in Phase II after implementing a clinic site champion., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
6. At-home specimen self-collection as an additional testing strategy for chlamydia and gonorrhoea: a systematic literature review and meta-analysis.
- Author
-
Smith AC, Thorpe PG, Learner ER, Galloway ET, and Kersh EN
- Subjects
- Humans, Self Care methods, Mass Screening methods, Gonorrhea diagnosis, Chlamydia Infections diagnosis, Specimen Handling methods, Chlamydia trachomatis isolation & purification, Neisseria gonorrhoeae isolation & purification
- Abstract
Introduction: Chlamydia trachomatis (Ct) and Neisseria gonorrhoeae (Ng) infections are often asymptomatic; screening increases early detection and prevents disease, sequelae and further spread. To increase Ct and Ng testing, several countries have implemented specimen self-collection outside a clinical setting. While specimen self-collection at home is highly acceptable to patients and as accurate as specimens collected by healthcare providers, this strategy is new or not being used in some countries. To understand how offering at home specimen self-collection will affect testing uptake, test results, diagnosis and linkage to care, when compared with collection in clinical settings, we conducted a systematic literature review and meta-analysis of peer-reviewed studies., Methods: We searched Medline, Embase, Global Health, Cochrane Library, CINAHL (EBSCOHost), Scopus and Clinical Trials. Studies were included if they directly compared specimens self-collected at home or in other non-clinical settings to specimen collection at a healthcare facility (self or clinician) for Ct and/or Ng testing and evaluated the following outcomes: uptake in testing, linkage to care, and concordance (agreement) between the two settings for the same individuals. Risk of bias (RoB) was assessed using Cochrane Risk of Bias (RoB2) tool for randomised control trials (RCTs)., Results: 19 studies, from 1998 to 2024, comprising 15 RCTs with a total of 62 369 participants and four concordance studies with 906 participants were included. Uptake of Ct or Ng testing was 2.61 times higher at home compared with clinical settings. There was a high concordance between specimens collected at home and in clinical settings, and linkage to care was not significantly different between the two settings (prevalence ratio 0.96 (95% CI 0.91-1.01))., Conclusion: Our meta-analysis and systematic literature review show that offering self-collection of specimens at home or in other non-clinical settings could be used as an additional strategy to increase sexually transmitted infection testing in countries that have not yet widely adopted this collection method., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
7. Embedding a novel screening programme for sexually transmitted infections (chlamydia and gonorrhoea) within an ambulatory emergency surgical assessment unit: an observational cohort study.
- Author
-
Ganesh D, Mahon C, Jones S, Please H, Hughes M, and Peckham-Cooper A
- Subjects
- Humans, Female, Adult, Cohort Studies, Young Adult, Adolescent, Prevalence, Incidence, Pelvic Inflammatory Disease epidemiology, Pelvic Inflammatory Disease microbiology, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases epidemiology, Gonorrhea diagnosis, Gonorrhea epidemiology, Chlamydia Infections diagnosis, Chlamydia Infections epidemiology, Abdominal Pain, Mass Screening methods
- Abstract
Background: A number of females with pelvic inflammatory disease will present to general surgical services with non-specific abdominal pain. Screening for sexually transmitted infections (STI) as an underlying cause is not routinely offered. We therefore established an STI screening programme for young females presenting to a same day emergency ambulatory surgical clinic as part of the diagnostic pathway. Data outlining the incidence and prevalence of STIs as the underlying cause of lower abdominal pain were collected., Methods: We conducted an observational cohort study. Self-collected vulvovaginal swabs for chlamydia and gonorrhoea were offered as part of a standardised diagnostic pathway for all females meeting inclusion criteria presenting with abdominal pain. Positive results were referred to our local sexual health team for treatment and contact tracing., Results: The cohort comprised 297 eligible patients; 259 participated, 20 patients declined testing and 18 samples were rejected as inadequate in the laboratory. 5.4% of swab results were positive (2 gonorrhoea and 12 chlamydia). All patients with positive swabs had presented with lower abdominal pain and of these only 21% had a documented sexual history., Conclusion: Undiagnosed STIs are prevalent, with significant fertility and public health risks. Young females seeking medical assessment for abdominal pain provide an opportunistic screening cohort with a likely subset of patients presenting with abdominal pain as a direct result of an STI. Our results demonstrate a high incidence of positive tests, suggesting further training of surgeons to include a sexual history in assessment of females with abdominal pain is vital., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
8. Epidemiological impact of Neisseria gonorrhoeae and Chlamydia trachomatis screening in men having sex with men: a modelling study.
- Author
-
Flaig J, Hocqueloux L, Palich R, Cuzin L, Robineau O, Pugliese P, Delpierre C, Voirin N, and Cotte L
- Subjects
- Humans, Male, Prevalence, Incidence, Adult, France epidemiology, Young Adult, Gonorrhea epidemiology, Gonorrhea diagnosis, Homosexuality, Male statistics & numerical data, Chlamydia trachomatis isolation & purification, Chlamydia Infections epidemiology, Chlamydia Infections diagnosis, Neisseria gonorrhoeae isolation & purification, Mass Screening statistics & numerical data
- Abstract
Objectives: The impact of the systematic screening of Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) in men having sex with men (MSM) on these pathogens' epidemiology remains unclear. We conducted a modelling study to analyse this impact in French MSM., Methods: We modelled NG and CT transmission using a site-specific deterministic compartmental model. We calibrated NG and CT prevalence at baseline using results from MSM enrolled in the Dat'AIDS cohort. The baseline scenario was based on 1 million MSM, 40 000 of whom were tested every 90 days and 960 000 every 200 days. Incidence rate ratios (IRRs) at steady state were simulated for NG, CT, NG and/or CT infections, for different combinations of tested sites, testing frequency and numbers of frequently tested patients., Results: The observed prevalence rate was 11.0%, 10.5% and 19.1% for NG, CT and NG and/or CT infections. The baseline incidence rate was estimated at 138.2 per year per 100 individuals (/100PY), 86.8/100PY and 225.0/100PY for NG, CT and NG and/or CT infections. Systematically testing anal, pharyngeal and urethral sites at the same time reduced incidence by 14%, 23% and 18% (IRR: 0.86, 0.77 and 0.82) for NG, CT and NG and/or CT infections. Reducing the screening interval to 60 days in frequently tested patients reduced incidence by 20%, 29% and 24% (IRR: 0.80, 0.71 and 0.76) for NG, CT and NG and/or CT infections. Increasing the number of frequently tested patients to 200 000 reduced incidence by 29%, 40% and 33% (IRR: 0.71, 0.60 and 0.67) for NG, CT and NG and/or CT infections. No realistic scenario could decrease pathogens' incidence by more than 50%., Conclusions: To curb the epidemic of NG and CT in MSM, it would not only be necessary to drastically increase screening, but also to add other combined interventions., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
9. Primum non-nocere : Is it time to stop screening for Neisseria gonorrhoeae and Chlamydia trachomatis in men who have sex with men taking HIV pre-exposure prophylaxis?
- Author
-
Vanbaelen T and Kenyon C
- Subjects
- Humans, Male, Gonorrhea prevention & control, Gonorrhea diagnosis, Homosexuality, Male, Pre-Exposure Prophylaxis, Neisseria gonorrhoeae isolation & purification, Chlamydia trachomatis isolation & purification, Chlamydia Infections prevention & control, Chlamydia Infections diagnosis, HIV Infections prevention & control, Mass Screening methods
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2024
- Full Text
- View/download PDF
10. Chlamydien.
- Author
-
Sigl S
- Subjects
- Humans, Female, Male, Chlamydia trachomatis, Chlamydia, Chlamydia Infections microbiology, Chlamydia Infections diagnosis
- Published
- 2024
- Full Text
- View/download PDF
11. Feasibility and acceptability of sexually transmitted infection screening during antenatal care of women in Dhaka, Bangladesh.
- Author
-
Karim R, Choudhury S, Bari F, Klausner JD, Nargis M, Khatun HA, Parveen S, Sheddika SA, Choudhury S, and Rahman F
- Subjects
- Humans, Female, Bangladesh epidemiology, Pregnancy, Adult, Chlamydia Infections diagnosis, Chlamydia Infections epidemiology, Young Adult, Chlamydia trachomatis isolation & purification, Gonorrhea diagnosis, Gonorrhea epidemiology, Neisseria gonorrhoeae isolation & purification, Adolescent, Trichomonas vaginalis isolation & purification, Papillomavirus Infections diagnosis, Papillomavirus Infections epidemiology, Papillomavirus Infections prevention & control, Prevalence, Prenatal Care, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases epidemiology, Patient Acceptance of Health Care statistics & numerical data, Feasibility Studies, Pregnancy Complications, Infectious diagnosis, Pregnancy Complications, Infectious epidemiology, Mass Screening methods
- Abstract
Background: Sexually transmitted infections (STIs) are a major public health concern worldwide. Untreated STIs may have serious sequelae, particularly in pregnant women. The objective of this study was to assess the feasibility and acceptability of screening and treating common STIs in women during pregnancy in Bangladesh., Methods: Women were enrolled from four maternity clinics/hospitals serving the lower-middle class population in Dhaka, Bangladesh. The participants were interviewed, and vaginal swab samples were collected by clinical staff. Specimens were tested for Neisseria gonorrhoeae , Chlamydia trachomatis , Trichomonas vaginalis and high-risk Human Papilloma Viruses (HPVs) using GeneXpert (Cepheid, Sunnyvale, California). Women were informed of their test results and were provided treatment for curable infections. A test of cure was performed., Results: Out of 1157 pregnant women approached, 1000 (86.4%) participated. Ninety-one percent women learned of their test results on the same day of testing. Out of the 996 valid results, 7 (0.7%) tested positive for Chlamydia trachomatis and 1 (0.1%) for Trichomonas vaginalis . There were no gonorrhoea cases. Out of the 971 women with valid results for high-risk HPVs, 46 (4.7%) tested positive., Conclusions: Screening women for STIs during antenatal care was highly feasible and well-accepted in Bangladesh. While the prevalence of common curable STIs was very low, hrHPV infection prevalence was moderately high. Our findings support period monitoring of STIs and continued prevention efforts for cervical cancer in Bangladesh., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
12. Evaluating Chlamydia trachomatis and Neisseria gonorrhoeae screening and treatment among asymptomatic pregnant women to prevent preterm birth and low birthweight in Gaborone, Botswana: A secondary analysis from a non-randomised, cluster-controlled trial.
- Author
-
Wynn A, Mussa A, Ryan R, Babalola CM, Hansman E, Ramontshonyana K, Tamuthiba L, Ndlovu N, Wilson ML, Ramogola-Masire D, Klausner JD, and Morroni C
- Subjects
- Humans, Female, Pregnancy, Adult, Botswana epidemiology, Infant, Newborn, Young Adult, Prenatal Care methods, Mass Screening methods, Anti-Bacterial Agents therapeutic use, Adolescent, Premature Birth prevention & control, Premature Birth epidemiology, Chlamydia Infections diagnosis, Chlamydia Infections epidemiology, Chlamydia Infections prevention & control, Gonorrhea epidemiology, Gonorrhea diagnosis, Gonorrhea prevention & control, Infant, Low Birth Weight, Pregnancy Complications, Infectious epidemiology, Pregnancy Complications, Infectious prevention & control, Pregnancy Complications, Infectious diagnosis, Chlamydia trachomatis isolation & purification, Neisseria gonorrhoeae isolation & purification
- Abstract
Objective: To evaluate the impact of screening and treating asymptomatic pregnant women for Chlamydia (C.) trachomatis and Neisseria (N.) gonorrhoeae infections on the frequency of preterm birth or low birthweight infants in Botswana., Design: Non-randomised, cluster-controlled trial., Setting: Four antenatal care clinics in Gaborone, Botswana., Population: Pregnant women aged ≥15 years, attending a first antenatal care visit, ≤27 weeks of gestation and without urogenital symptoms were eligible., Methods: Participants in the intervention clinics received screening (GeneXpert®, Cepheid) during pregnancy and at the postnatal visit. Participants in the standard-of-care clinics received screening at the postnatal visit only. We used multivariable logistic regression and post-estimation predictive margins analysis. Post-hoc analysis was conducted among sub-samples stratified by parity., Main Outcome Measures: Preterm birth (<37 weeks of gestation) and low birthweight (<2500 g)., Results: After controlling for parity, hypertension, antenatal care visits and clinic site, the predicted prevalence of preterm birth or low birthweight was lower in the intervention arm (11%) compared with the standard-of-care arm (16%) (adjusted odds ratio [aOR] 0.59; 95% confidence interval [CI] 0.28-1.24). In post-hoc analysis, the intervention was more effective than the standard-of-care (aOR 0.20; 95% CI 0.07-0.64) among nulliparous participants., Conclusion: A C. trachomatis and N. gonorrhoeae infection screening and treatment intervention among asymptomatic pregnant women may have reduced preterm birth or low birthweight outcomes, but results were not statistically significant. Post-hoc analysis found that the intervention reduced adverse outcomes among nulliparous participants., (© 2024 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
13. Addressing Challenges in Chlamydia trachomatis Detection: A Comparative Review of Diagnostic Methods.
- Author
-
Rodrigues R, Silva AR, Sousa C, and Vale N
- Subjects
- Humans, Sensitivity and Specificity, Female, Male, Chlamydia trachomatis isolation & purification, Chlamydia trachomatis genetics, Chlamydia Infections diagnosis, Nucleic Acid Amplification Techniques methods
- Abstract
Chlamydial infections are one of the most common sexually transmitted bacterial infections worldwide, which is related to serious consequences for the mental, sexual, and reproductive health of women and men. The infection is commonly asymptomatic; consequently, screening programs for infection control have been introduced in some countries. The detection methods of Chlamydia trachomatis infections have evolved since the establishment of the first gold-standard detection method in the 1970s, the culture assay. Over the decades, many efforts were made to find methods with a higher sensitivity, until the 1990s, when, as a result of advances in molecular biology, nucleic acid amplification tests came into use with more sensitivity, and, currently, there are several available with which to detect infection. Therefore, herein, we will review the main methods used for CT detection and the differences between them, in terms of targets, infections that can be detected, sensitivity, and specificity. We will focus on some of the FDA-approved CT detection tests and highlight the major advantages and superiority of using molecular biology techniques. In addition, we will examine the larger challenges and limitations of the methods currently in use and discuss how they might be surpassed. Moreover, in this review, we will describe the next step to carry out after testing positive for CT infection.
- Published
- 2024
- Full Text
- View/download PDF
14. [A national network of molecular tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae: a pilot implementation experience in Brazil].
- Author
-
Gaspar PC, Miranda AE, Bigolin A, Morais AAC, Aragón MG, Morais JAV, Alonso Neto JB, Lannoy LH, Sanchez MN, Cravo Neto DB, Bermúdez XPCD, and Benzaken AS
- Subjects
- Humans, Brazil, Male, Female, Pilot Projects, Adult, Young Adult, National Health Programs, Adolescent, Molecular Diagnostic Techniques methods, Chlamydia Infections diagnosis, Chlamydia trachomatis isolation & purification, Chlamydia trachomatis genetics, Neisseria gonorrhoeae isolation & purification, Neisseria gonorrhoeae genetics, Gonorrhea diagnosis
- Abstract
This study aimed to know the opinion of professionals participating in an experiment to implement a pilot for molecular tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae at the Brazilian Unified National Health System (SUS). The detection rate of C. trachomatis and/or N. gonorrhoeae and the factors associated with infection were determined. The strategy included laboratories belonging to the HIV and viral hepatitis viral load network. Testing targeted people who are more vulnerable to sexually transmitted infections and collected urine samples and/or vaginal, endocervical, and/or male urethral swabs. Questionnaires were sent to state managers and laboratory professionals about the implementation of the pilot. Reviews were overall positive. Weaknesses included difficulties changing work processes, lack of human resources, poorly sensitized care professionals, and absence of primary urine tubes, the only input not provided. Strengths included the centralized acquisition of tests, sharing of equipment, and storage of samples at room temperature. Of the 16,177 people who were tested, 1,004 (6.21%) were positive for C. trachomatis; 1,036 (6.4%), for N. gonorrhoeae; and 239 (1.48%), for C. trachomatis/N. gonorrhoeae . Detection of any infection occurred more frequently in young people (≤ 24 vs. > 24 years) (adjOR = 2.65; 95%CI: 2.38-2.96), men (adjOR = 1.95; 95%CI: 1.72-2.21), brown/black individuals (adjOR = 1.06; 95%CI: 1.05-1.11), those in Southeastern Brazil (adjOR = 1.08; 95%CI: 1.02-1.13), and in urethral secretion samples (adjOR = 1.46; 95%CI: 1.41-1.52). Results show the importance of making testing available nationwide, which supported the implementation of a definitive network to detection C. trachomatis/N. gonorrhoeae in SUS.
- Published
- 2024
- Full Text
- View/download PDF
15. Chlamydia trachomatis Seroassays Used in Epidemiologic Research: A Narrative Review and Practical Considerations.
- Author
-
Waters MB, Hybiske K, Ikeda R, Kaltenboeck B, Manhart LE, Kreisel KM, and Khosropour CM
- Subjects
- Humans, Sensitivity and Specificity, Female, Prevalence, Nucleic Acid Amplification Techniques methods, United States epidemiology, Epidemiologic Studies, Chlamydia trachomatis isolation & purification, Chlamydia Infections epidemiology, Chlamydia Infections diagnosis
- Abstract
Chlamydia trachomatis (CT) is a sexually transmitted infection that can lead to adverse reproductive health outcomes. CT prevalence estimates are primarily derived from screening using nucleic acid amplification tests (NAATs). However, screening guidelines in the United States only include particular subpopulations, and NAATs only detect current infections. In contrast, seroassays identify past CT infections, which is important for understanding the public health impacts of CT, including pelvic inflammatory disease and tubal factor infertility. Older seroassays have been plagued by low sensitivity and specificity and have not been validated using a consistent reference measure, making it challenging to compare studies, define the epidemiology of CT, and determine the effectiveness of control programs. Newer seroassays have better performance characteristics. This narrative review summarizes the "state of the science" for CT seroassays that have been applied in epidemiologic studies and provides practical considerations for interpreting the literature and employing seroassays in future research., Competing Interests: Potential conflicts of interest. L. E. M. has received research materials and research funding from Hologic, Inc, and Nabriva Therapeutics, as well as an honorarium from Health Advances. C. M. K. has received donations of study collection kits and reagents from Hologic, Inc, for research studies outside the submitted work. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
16. Overcoming analytical and preanalytical challenges associated with extragenital home collected STI specimens.
- Author
-
Hockman BE, Qi M, Rotblatt H, Borenstein L, Flynn RA, Muldrow RA, Rajagopalan S, and Greene DN
- Subjects
- Humans, Female, Male, Adult, Pharynx microbiology, Sexually Transmitted Diseases diagnosis, Rectum microbiology, Young Adult, Sensitivity and Specificity, Specimen Handling methods, Chlamydia trachomatis isolation & purification, Gonorrhea diagnosis, Gonorrhea microbiology, Neisseria gonorrhoeae isolation & purification, Chlamydia Infections diagnosis, Chlamydia Infections microbiology
- Abstract
Home sample collection for sexually transmitted infection (STI) screening options can improve access to sexual healthcare across communities. For Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), genital infections have classically been the focus for remote collection options. However, infections may go undiagnosed if sampling is limited to urogenital sites because some individuals only participate in oral and/or anal intercourse. Here we evaluated samples for CT/NG detection after several pre-analytical collection challenges. A paired provider to self-collection validation was performed on rectal [ n = 162; 22 + for CT and 9 + for NG by provider-collected (PC)] and throat ( N = 158; 2 + for CT and 11 + for NG by provider-collected) swabs. The positive percent agreement for CT and NG ranged from 90.9% to 100%. The discrepancies were more often positive on self-collected (SC) ( n = 9 SC+/PC-; n = 1 PC+/SC-; n = 1 PC+/SC Equiv.; n = 2 PC-/SC Equiv.). An empirical limit of detection (LoD) lower than the manufacturer's claim (0.031 vs 2.5 IFU/mL for CT and 0.063 vs 124.8 CFU/ml for NG, respectively) was used to challenge additional variables. Common hand contaminants, including soap, hand sanitizer, lotion, and sunscreen were added to known positive (3× empirical LoD) or negative samples and did not influence detection. Samples at 2× and 10× the empirical LoD were challenged with extreme temperature cycling and extended room temperature storage. Detection was not affected by these conditions. These results indicate that remote self-collection is an appropriate method of sample acquisition for detecting extragenital CT/NG infections. Additionally, they provide a foundation towards meeting the regulatory standards for commercial testing of home collected extragenital samples., Importance: There is a clinical need for expanded extragenital bacterial sexually transmitted infection (STI) testing options, but the current regulatory landscape limits the wide-spread promotion and adoption of such services. Improved access, particularly for the LGBTQ+ community, can be achieved by validating testing for specimens that are self-collected at a remote location and arrive at the laboratory via a postal carrier or other intermediary route. Here we provide valuable data showing that self-collected samples for anal and oropharyngeal STI testing are equally or increasingly sensitive compared with those collected by a provider. We systematically consider the effects of storage time, exposure to temperature extremes, and the addition of common toiletries on results., Competing Interests: At the time of writing, B.E.H., R.A.M., and D.N.G. received salary compensation from LetsGetChecked. D.N.G. additionally received scientific advisory compensation from Abbott Diagnostics.
- Published
- 2024
- Full Text
- View/download PDF
17. Prevalence of Four Sexually Transmitted Infection Pathogens Detected in Urine and Genital Tract Secretion in Hangzhou, China.
- Author
-
Wang X, Zhong C, Zhao X, and Song Q
- Subjects
- Humans, Male, Female, China epidemiology, Adult, Middle Aged, Adolescent, Prevalence, Young Adult, Retrospective Studies, Aged, Aged, 80 and over, Gonorrhea epidemiology, Gonorrhea diagnosis, Gonorrhea urine, Gonorrhea microbiology, Chlamydia Infections epidemiology, Chlamydia Infections urine, Chlamydia Infections diagnosis, Chlamydia Infections microbiology, Sexually Transmitted Diseases epidemiology, Sexually Transmitted Diseases urine, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases microbiology
- Abstract
Background: Sexually transmitted infections (STIs) increase gradually and have become a public health problem in the world. UU, CT, NG, and MG are four common STI pathogens. Our retrospective study analyzed the clinical situation and the laboratory data of patients infected with the four pathogens. The prevalence of the four pathogens, detected in urine and genital tract secretion, was studied in Hangzhou, China., Methods: A total of 3,168 male and female patients were randomly selected from February 2023 to February 2024. Urine and genital secretions were collected, and four STI pathogens were controlled for detection. Data were collected from the hospital's electronic medical records, and SPSS 25.0 software was used to perform a statistical analysis., Results: Among 3,168 patients, a total of 1,527 were detected as positive, and the positive rate was 48.20%. The age of patients ranged from 13 - 98 years, with an average age of 45.6. The total of patients consisted of 2,191 males and 977 females, which had a significant difference (p < 0.05). Specimens were mainly collected from the Department of Dermatovenerology, Urological Surgery, Obstetrics and Gynecology, and so on. The positive rate was statistically different between male and female patients (p < 0.05). Single infection performed a main role and accounted for 79.57% of all of the positive patients. In the ≤ 20 age group, the positive rate was the highest and was as high as 77.65%. In detail, single infection caused by UU dominated, especially in the 21 - 30 age group. Double infection caused by UU and CT and triple infection caused by UU, CT, and NG were the majority, both especially in the 21 - 30 age group. There were significant differences in the positive rates in the different age groups and in the four pathogens (p < 0.05). Quadruple infection was very rare and had only been detected in one patient., Conclusions: The prevalence of the four pathogens in Hangzhou was different from other regions. More male than female patients, more single than multiple infections, and more single and multiple infections occurring in young people were the features in Hangzhou. The study would provide reference for prevention, diagnosis, and treatment of STI.
- Published
- 2024
- Full Text
- View/download PDF
18. Clinical Evaluation of the Alinity m STI Multiplex PCR Assay.
- Author
-
Lima A, Uy D, Kostera J, and Silbert S
- Subjects
- Humans, Female, Male, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases microbiology, Chlamydia Infections diagnosis, Mycoplasma Infections diagnosis, Sensitivity and Specificity, Adult, United States, Trichomonas Vaginitis diagnosis, Trichomonas Vaginitis epidemiology, Reagent Kits, Diagnostic, Chlamydia trachomatis isolation & purification, Chlamydia trachomatis genetics, Multiplex Polymerase Chain Reaction methods, Neisseria gonorrhoeae isolation & purification, Neisseria gonorrhoeae genetics, Trichomonas vaginalis isolation & purification, Trichomonas vaginalis genetics, Mycoplasma genitalium isolation & purification, Mycoplasma genitalium genetics, Gonorrhea diagnosis
- Abstract
Background: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are routinely tested and reported; however, Trichomonas vaginalis (TV) is the most common sexually transmitted infection (STI) in the United States and the prevalence of Mycoplasma genitalium (MG) infections is likely higher than estimated. We examined the clinical performance of the Alinity m STI assay for detection and surveillance of CT/NG/TV/MG in urine specimens from patients at a large academic medical center., Methods: Urine specimen from 198 patients was tested in this evaluation. Alinity m STI and Aptima Combo 2 CT/NG and TV assay (Panther System) results were compared, with discrepant results run on the cobas 6800 CT/NG, TV/MG assays. Analyzer turnaround times, time from loading the specimen on the analyzer to results reporting, were determined for Alinity m and Panther systems., Results: Overall percent agreements of the Alinity m in comparison with the Aptima and cobas assays for CT, NG, TV, and MG were 99.5% (97.2%, 99.9%), 99.5% (97.2%, 99.9%), 98.4% (95.5%, 99.5%), and 86.4% (66.7%, 95.3), respectively. There were 5 discrepant samples (CT, 1; NG, 1; TV, 3) between the Alinity m and the Aptima assays, and 3 MG discrepant samples between the Alinity m STI and cobas 6800. Two of the 5 Aptima and Alinity m discrepant samples were resolved as they yielded similar results on both Alinity m and cobas 6800. TV and MG infections comprised 54% of the positive samples and were more often asymptomatic than CT and NG infections. Analyzer turnaround time was 3 hours 25 minutes for the Aptima CT/NG, 3 hours 25 minutes for Aptima TV, and 1 hour 55 minutes for Alinity m STI assay., Conclusions: The Alinity m STI assay allows for fast and simultaneous detection of the 4 major STI pathogens, which can facilitate surveillance and provide accurate results to help clinicians diagnose for initiation of appropriate treatment., Competing Interests: Conflict of Interest and Sources of Funding: J.K. is an employee of Abbott Laboratories. This study was funded by a grant from Abbott Laboratories., (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Sexually Transmitted Diseases Association.)
- Published
- 2024
- Full Text
- View/download PDF
19. Underlying Reasons for Primary Care Visits Where Chlamydia Testing Was Performed in the United States, 2019 to 2022.
- Author
-
Tao G, Hufstetler K, He L, Patel CG, Rehkopf D, Phillips RL, and Pearson WS
- Subjects
- Humans, Female, United States, Male, Adult, Adolescent, Young Adult, Middle Aged, Registries, Chlamydia Infections diagnosis, Primary Health Care, Mass Screening
- Abstract
Background: In the United States, most chlamydia cases are reported from non-sexually transmitted disease clinics, and there is limited information focusing on the reasons for chlamydia testing in private settings. These analyses describe clinical visits to primary care providers where chlamydia testing was performed to help discern between screening and diagnostic testing for chlamydia., Methods: Using the largest primary care clinical registry in the United States, the PRIME registry, chlamydia tests were identified using Current Procedural Terminology procedure codes and categorized as diagnostic testing for sexually transmitted infection (STI)-related symptoms, screening for chlamydia, or "other," based on Classification of Diseases, Tenth Revision Evaluation and Management codes selected for visits., Results: Of 120,013 clinical visits with chlamydia testing between January 1, 2019, and December 31, 2022, 70.4% were women; 20.6% were with STI-related symptoms, 59.9% were for screening, and 19.5% for "other" reasons. Of those 120,013 clinical visits with chlamydia testing, the logit model showed that patients were significantly more likely to have STI-related symptoms if they were female than male, non-Hispanic Black than non-Hispanic White, aged 15 to 24 years than aged ≥45 years, and resided in the South than in the Northeast., Conclusion: It is important to know what proportion of chlamydial infections is identified through screening programs and to have this information stratified by demographics. The inclusion of laboratory results could further facilitate a better understanding of the impact of chlamydia screening programs on the identification and treatment of chlamydia in private office settings in the United States., Competing Interests: Conflict of Interest and Sources of Funding: None declared., (Copyright © 2024 American Sexually Transmitted Diseases Association. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
20. Sexually transmitted infections in pregnancy and adverse pregnancy outcomes: A retrospective cohort study.
- Author
-
Govender V, Moodley D, Naidoo M, Connoly C, Ngcapu S, and Abdool Karim Q
- Subjects
- Humans, Female, Pregnancy, Retrospective Studies, South Africa epidemiology, Adult, Young Adult, Adolescent, Infant, Low Birth Weight, Infant, Newborn, Chlamydia Infections epidemiology, Chlamydia Infections diagnosis, Mycoplasma genitalium isolation & purification, Herpes Genitalis epidemiology, Herpes Genitalis complications, Prevalence, Logistic Models, Trichomonas vaginalis isolation & purification, Herpesvirus 2, Human isolation & purification, Prenatal Care, Trichomonas Vaginitis epidemiology, Trichomonas Vaginitis diagnosis, Pregnancy Complications, Infectious epidemiology, Pregnancy Outcome, Sexually Transmitted Diseases epidemiology, Sexually Transmitted Diseases diagnosis, Premature Birth epidemiology
- Abstract
Objective: There is a high prevalence and incidence rate of asymptomatic sexually transmitted infections (STIs) during pregnancy in adolescent girls and young women in Africa. The association between STIs and pregnancy outcomes in a hyperepidemic HIV setting has not been well described., Methods: Pregnant women, HIV-1 negative and <28 weeks' gestation at three primary health clinics in KwaZulu-Natal, South Africa were enrolled from February 2017 to March 2018. Vaginal swabs collected at the first and later antenatal visits were stored and retrospectively tested for HSV-2, Trichomonas vaginalis, Chlamydia trachomatis and Neisseria gonorrhoeae at the end of the study. The association between STIs detected at first and later antenatal visits and pregnancy outcome was assessed using multivariable logistic regression models adjusted for maternal age and treatment received for symptomatic STIs., Results: Testing positive Mycoplasma genitalium at the first antenatal visit was significantly associated with low birth weight (odds ratio [OR] 5.22; 95% confidence interval [CI]: 1.10-15.98). Testing positive for T. vaginalis at the repeat visit was significantly associated with preterm births (OR 2.37; 95% CI: 1.11-5.03), low birth weight (OR 2.56; 1.16-5.63) and a composite adverse pregnancy outcome (OR 2.11; 95% CI: 1.09-4.08). Testing positive for HSV-2 at the repeat visit was also likely associated with experiencing a preterm birth or any adverse pregnancy outcome (OR 3.39; 95% CI: 0.86-13.3) (P = 0.096)., Conclusions: Among predominantly asymptomatic STIs, M. genitalium detected at baseline visit was significantly associated with low birth weight, while T. vaginalis detected at the repeat visit in later pregnancy was significantly associated with preterm birth. Further research is warranted to study the impact of etiological testing of STIs at more than one antenatal visit and empirical treatment on pregnancy outcomes., (© 2024 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.)
- Published
- 2024
- Full Text
- View/download PDF
21. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium and risk factors among pregnant women in Brazil: Results from the national molecular diagnosis implementation project.
- Author
-
Miranda AE, Gaspar PC, Schörner MA, Barazzetti FH, Dias GB, Bigolin A, Pascom ARP, Barreira D, and Bazzo ML
- Subjects
- Humans, Female, Brazil epidemiology, Pregnancy, Adult, Cross-Sectional Studies, Adolescent, Prevalence, Young Adult, Risk Factors, Middle Aged, Sexually Transmitted Diseases epidemiology, Sexually Transmitted Diseases diagnosis, Mycoplasma genitalium isolation & purification, Mycoplasma Infections epidemiology, Mycoplasma Infections diagnosis, Gonorrhea epidemiology, Gonorrhea diagnosis, Neisseria gonorrhoeae isolation & purification, Trichomonas vaginalis isolation & purification, Pregnancy Complications, Infectious epidemiology, Pregnancy Complications, Infectious diagnosis, Chlamydia trachomatis isolation & purification, Chlamydia Infections epidemiology, Chlamydia Infections diagnosis, Trichomonas Vaginitis epidemiology, Trichomonas Vaginitis diagnosis
- Abstract
Background: Sexually transmitted infections (STIs) are a public health problem. The aim of the present study was to assess the prevalence and risk factors associated with at least one STI (Chlamydia trachomatis [CT], Neisseria gonorrhoeae [NG], Trichomonas vaginalis [TV], and Mycoplasma genitalium [MG]) in Brazil., Methods: A cross-sectional study was conducted using secondary data from the pilot implementation of the National Service for molecular diagnosis of CT, NG, TV, and MG in pregnancy. We obtained Ministry of Health surveillance data from the implementation project. Data encompassing pregnant women aged 15-49 years from public antenatal clinics in Brazil in 2022 were included., Results: A total of 2728 data of pregnant women were analyzed. The prevalence of at least one infection was 21.0% (573), with the highest prevalence in the Southeast region (23.3%) and the lowest in the Center-West region (15.4%). The prevalence of CT was 9.9% (270), NG 0.6% (16), TV 6.7% (184), and MG 7.8% (212). Factors associated with any infection were from 15 to 24 years (AOR = 1.93; 95% CI: 1.58-2.35); reported family income up to US$400 (AOR = 1.79; 95% CI: 1.03-3.34); declared not living maritally with their partners (AOR = 1.90, 95% CI: 1.52-2.37) and had more than one sexual partner in their lifetime (AOR = 2.09, 95% CI: 1.55-2.86)., Conclusion: This study showed a high prevalence of at least one STI among pregnant women in Brazil, particularly among younger women. It also provides up-to-date national data on CT, NG, TV, and MG infections in this population. These findings underscore the importance of enhancing access to STI screening for young pregnant women within the Brazilian public health system., (© 2024 International Federation of Gynecology and Obstetrics.)
- Published
- 2024
- Full Text
- View/download PDF
22. Should We Be Testing for Mycoplasma genitalium on Initial Presentation? Trends in Persistent/Recurrent Urethritis Among Men Presenting for Care in STD Clinics, 2015-2019, STD Surveillance Network.
- Author
-
Llata E, Tromble E, Schumacher C, Huspeni D, Asbel L, Pathela P, Kohn R, Kerani RP, Barbee L, and Bachmann L
- Subjects
- Humans, Male, Retrospective Studies, Adult, Gonorrhea drug therapy, Gonorrhea diagnosis, Gonorrhea epidemiology, Young Adult, Chlamydia Infections drug therapy, Chlamydia Infections diagnosis, Chlamydia Infections epidemiology, Anti-Bacterial Agents therapeutic use, Middle Aged, Sexually Transmitted Diseases drug therapy, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases epidemiology, Azithromycin therapeutic use, Azithromycin administration & dosage, Adolescent, Doxycycline therapeutic use, Urethritis drug therapy, Urethritis diagnosis, Urethritis microbiology, Urethritis epidemiology, Mycoplasma genitalium isolation & purification, Mycoplasma Infections drug therapy, Mycoplasma Infections diagnosis, Mycoplasma Infections epidemiology, Recurrence
- Abstract
Background: Mycoplasma genitalium is a major contributor to persistent/recurrent urethritis cases. However, there are limited published studies on recent trends of persistent/recurrent urethritis., Methods: A retrospective analysis was conducted of men presenting with symptomatic urethritis in 16 sexually transmitted disease (STD) clinics from 2015 to 2019. Poisson regression was used to assess trends in the annual proportions of urethritis episodes with follow-up (FU) characterized with persistent/recurrent urethritis symptoms. Results were also stratified by results of chlamydia (CT) and gonorrhea (NG) testing and treatment prescribed., Results: There were 99,897 urethritis episodes, from 67,546 unique men. The proportion of episodes with persistent/recurrent symptomatic FU visits increased 50.8% over a 4-year period (annual percentage change [APC], 11.3%; 95% confidence interval [CI], 6.5-16.3). Similar trends were observed in nonchlamydial nongonococcal urethritis episodes (APC, 12.7%; 95% CI, 6.8-18.9) but increases among those positive for NG (APC, 12.1%; 95% CI, -2.3 to -28.5) or for CT (APC, 7.3%; 95% CI, -6.7 to 23.5) were not statistically significant. Among episodes who received azithromycin as first-line treatment, increases in the proportion of persistent/recurrent FU visits were observed (APC, 12.6%; 95% CI, 8.6-16.7). For episodes where first-line treatment was doxycycline, no significant increases were detected (APC, 4.3%; 95% CI, -0.3 to 9.2)., Conclusions: We found an increase in the proportion of urethritis episodes with persistent or recurrent symptoms over time. Given these observed trends in episodes negative for NG or CT, an etiology not detectable by routine diagnostics was a likely factor in increased persistence, suggesting patients with urethritis may benefit from diagnostic testing for M. genitalium during an initial symptomatic presentation., Competing Interests: Conflict of Interest and Sources of Funding: None declared., (Copyright © 2024 American Sexually Transmitted Diseases Association. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
23. Performance of Cepheid CT/NG Xpert rapid PCR test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae at a tertiary care centre in North India.
- Author
-
Sethi S, Gudisa R, Sharma N, Sreenivasan P, Gupta P, Chaudary H, Narang T, and Bagga R
- Subjects
- Humans, India, Female, Male, Adult, Young Adult, Molecular Diagnostic Techniques methods, Middle Aged, Adolescent, Chlamydia trachomatis genetics, Chlamydia trachomatis isolation & purification, Neisseria gonorrhoeae genetics, Neisseria gonorrhoeae isolation & purification, Tertiary Care Centers, Gonorrhea diagnosis, Gonorrhea microbiology, Chlamydia Infections diagnosis, Chlamydia Infections microbiology, Sensitivity and Specificity, Polymerase Chain Reaction methods
- Abstract
Introduction: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are prevalent causes of sexually transmitted infections (STIs) globally, leading to substantial morbidity and transmission risks., Methods: This study evaluates the diagnostic efficacy of Xpert CT/NG compared to conventional PCR and culture methods in 121 patients at a tertiary care centre in North India., Results: Xpert CT/NG demonstrated high sensitivity (85.8%) and specificity (96.3%) outperforming conventional PCR. Xpert CT/NG's rapidity and accuracy underscore its utility in timely diagnosis and control of STIs., Conclusion: As sexually transmitted infections pose a serious health concern implementation of such rapid diagnostic methods/point of care testing methods are to be implemented for early diagnosis., (Copyright © 2024 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
24. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections among sexual assault victims referred to three French clinical forensic units.
- Author
-
Rossi LH, Gonthier H, Le Gallo A, Baccino E, Jousset N, and Peyron PA
- Subjects
- Humans, Female, France epidemiology, Male, Retrospective Studies, Adult, Prevalence, Young Adult, Adolescent, Sex Offenses statistics & numerical data, Middle Aged, Child, Forensic Medicine, Gonorrhea epidemiology, Gonorrhea diagnosis, Chlamydia Infections epidemiology, Chlamydia Infections diagnosis, Crime Victims statistics & numerical data, Chlamydia trachomatis isolation & purification, Neisseria gonorrhoeae isolation & purification
- Abstract
Background: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are the most common bacterial sexually transmitted infections (STIs) worldwide. These STIs are frequently asymptomatic, which often delays diagnosis and treatment with the risk of serious long-term complications. Current French recommendations call for targeted screening of populations considered to be at risk, including victims of sexual assault. However, no recent data on the prevalence of these STIs in this population are available in France. The aim of this study was therefore to determine the prevalence of CT/NG infections among victims of sexual assault attending three Clinical Forensic Units (CFUs)., Methods: We retrospectively reviewed the forensic records of patients aged over 12 years reporting a sexual assault and referred between January 1, 2020 and December 31, 2021 to the CFU of Montpellier, Angers or Saint-Denis de La Réunion. Patients who had been screened for CT and NG infections were included., Results: 341 alleged victims of sexual assault (324 women, 17 men, median age = 23 years) were screened for CT/NG STIs during the inclusion period (Montpellier, n=196; Angers, n=63; Saint-Denis, n=82). The median time between the sexual assault and the examination was 1 day. CT and NG were detected in 28 patients (8.2 %) and 8 patients (2.3 %) respectively, with no men tested positive. Positive results concerned genital samples, except for two CT-positive anorectal samples and one NG-positive oropharyngeal sample. Two patients (0.6 %) were co-infected with CT/NG. The overall prevalence of CT/NG STIs was 10.0 % and was higher in the 18-24 age group, reaching 13.2 % for CT., Conclusions: This multicenter study confirms the high prevalence of CT/NG STIs in victims of sexual assault, and the vulnerability of the youngest age groups to these infections. Systematic screening for CT/NG STIs at the time of the forensic examination is the key to early diagnosis and effective treatment to prevent transmission and subsequent complications in these patients., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
25. Economic evaluation alongside a clinical trial of near-to-patient testing for sexually transmitted infections.
- Author
-
Zhang Y, Vodstrcil LA, Htaik K, Plummer EL, De Petra V, Sen MG, Williamson DA, Owlad M, Murray G, Chow EP, Fairley CK, Bradshaw CS, and Ong JJ
- Subjects
- Humans, Male, Female, Gonorrhea diagnosis, Gonorrhea economics, Gonorrhea drug therapy, Australia, Adult, Cost-Benefit Analysis, Chlamydia Infections diagnosis, Chlamydia Infections economics, Chlamydia Infections drug therapy, Chlamydia trachomatis, Neisseria gonorrhoeae isolation & purification, Mycoplasma genitalium, Mass Screening economics, Mass Screening methods, Mycoplasma Infections diagnosis, Mycoplasma Infections drug therapy, Mycoplasma Infections economics, Urethritis diagnosis, Urethritis economics, Urethritis drug therapy, Urethritis microbiology, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases economics, Sexually Transmitted Diseases drug therapy
- Abstract
Background: Current clinical care for common bacterial STIs (Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Mycoplasma genitalium (MG)) involves empiric antimicrobial therapy when clients are symptomatic, or if asymptomatic, waiting for laboratory testing and recall if indicated. Near-to-patient testing (NPT) can improve pathogen-specific prescribing and reduce unnecessary or inappropriate antibiotic use in treating sexually transmitted infections (STI) by providing same-day delivery of results and treatment., Methods: We compared the economic cost of NPT to current clinic practice for managing clients with suspected proctitis, non-gonococcal urethritis (NGU), or as an STI contact, from a health provider's perspective. With a microsimulation of 1000 clients, we calculated the cost per client tested and per STI- and pathogen- detected for each testing strategy. Sensitivity analyses were conducted to assess the robustness of the main outcomes. Costs are reported as Australian dollars (2023)., Results: In the standard care arm, cost per client tested for proctitis, NGU in men who have sex with men (MSM) and heterosexual men were the highest at $247.96 (95% Prediction Interval (PI): 246.77-249.15), $204.23 (95% PI: 202.70-205.75) and $195.01 (95% PI: 193.81-196.21) respectively. Comparatively, in the NPT arm, it costs $162.36 (95% PI: 161.43-163.28), $158.39 (95% PI: 157.62-159.15) and $149.17 (95% PI: 148.62-149.73), respectively. Using NPT resulted in cost savings of 34.52%, 22.45% and 23.51%, respectively. Among all the testing strategies, substantial difference in cost per client tested between the standard care arm and the NPT arm was observed for contacts of CT or NG, varying from 27.37% to 35.28%., Conclusion: We found that NPT is cost-saving compared with standard clinical care for individuals with STI symptoms and sexual contacts of CT, NG, and MG., Competing Interests: Declaration of Competing Interest CSB and CKF were supported by an Australian National Health and Medical Research Council Leadership Investigator Grant (GNT1173361 and GNT1172900, respectively). JJO and EPFC are supported by an Australian National Health and Medical Research Council Emerging Leadership Investigator Grant (GNT1193955 and GNT1172873). YZ is supported by an Australian Government Research Training Program (RTP) scholarship. All other authors declare no competing interests., (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
26. Claims for Contraceptive Services and Chlamydia and Gonorrhea Testing Among Insured Adolescent and Young Adult Females in the United States.
- Author
-
Kulkarni AD, Tepper N, Patel CG, Monsour M, Tevendale HD, Brittain AW, Whiteman M, and Koumans EH
- Subjects
- Humans, Female, United States, Adolescent, Young Adult, Insurance, Health statistics & numerical data, Insurance Claim Review, Contraception statistics & numerical data, Adult, Gonorrhea diagnosis, Gonorrhea ethnology, Chlamydia Infections diagnosis, Medicaid statistics & numerical data
- Abstract
Objective: To examine claims for reversible prescription contraceptives and chlamydia and gonorrhea testing among commercially and Medicaid-insured adolescent and young adult (AYA) females in the United States. Methods: Using IBM MarketScan Research Databases, we identified sexually active, nonpregnant AYA (15- to 24-year-old) females enrolled in 2018. We examined claims for reversible prescription contraceptives and chlamydia and gonorrhea testing, using drug names and diagnosis/procedure codes, by age-group in commercially and Medicaid-insured separately and by race/ethnicity in Medicaid-insured. Results: Among 15- to 19-year-old and 20- to 24-year-old females, 67.2% and 67.9% of commercially insured and 57.3% and 54.0% of Medicaid-insured, respectively, had claims for reversible prescription contraceptives in 2018. Across insurance types among both age-groups, the most common claim for contraceptives was prescription for combined oral contraceptives. Among Medicaid-insured 15- to 19-year-olds, claims for contraceptives ranged from 42.6% for Hispanic females to 63.4% for non-Hispanic White females; among Medicaid-insured 20- to 24-year-olds, claims ranged from 50.4% for non-Hispanic Black females to 57.0% for non-Hispanic White females. Approximately half of the commercially and Medicaid-insured females had claims for chlamydia and gonorrhea testing. Non-Hispanic Black females had the highest percentages of claims for chlamydia testing (56.3% among 15- to 19-year-olds and 61.1% among 20- to 24-year-olds) and gonorrhea testing (61.6% among 15- to 19-year-olds and 64.9% among 20- to 24-year-olds). Conclusion: Approximately, two-thirds of commercially insured and more than half of Medicaid-insured, sexually active, nonpregnant AYA females had claims for reversible prescription contraceptives. Race/ethnicity data were available for Medicaid-insured females, and there were differences in claims for contraceptives and chlamydia and gonorrhea testing by race/ethnicity. Half of the AYA females had claims for chlamydia and gonorrhea testing suggesting missed opportunities.
- Published
- 2024
- Full Text
- View/download PDF
27. Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women.
- Author
-
Cordioli M, Gios L, Mirandola M, Zorzi A, Barbara C, Padovese V, Hancali A, Oumzi H, Kularatne R, Jiang TT, Caceres CF, Vargas S, Alvarez CS, Camey E, Peeling RW, Unemo M, Ballard R, Blondeel K, Kiarie J, Thwin SS, and Toskin I
- Subjects
- Humans, Male, Female, Prospective Studies, Mass Screening methods, Trichomonas vaginalis isolation & purification, Sexually Transmitted Diseases diagnosis, Trichomonas Vaginitis diagnosis, Trichomonas Vaginitis epidemiology, Multicenter Studies as Topic, Sensitivity and Specificity, Adult, Point-of-Care Systems, Chlamydia Infections diagnosis, Gonorrhea diagnosis, Point-of-Care Testing, Homosexuality, Male
- Abstract
Introduction: In 2016, WHO estimated there were roughly 374 million new infections among adults of the following four curable sexually transmitted infections (STIs): chlamydia (caused by Chlamydia trachomatis (CT)), gonorrhoea ( Neisseria gonorrhoeae (NG)), syphilis ( Treponema pallidum ) and trichomoniasis ( Trichomonas vaginalis (TV)). Accurate point-of-care tests (POCTs) for screening of genital and extragenital CT, NG and TV infections are of great value and have been developed during recent decade. Several tests are commercially available and have shown encouraging performance compared with 'gold-standard' reference tests in laboratory-based studies. However, there is limited data on their clinical performance, including at the POC. Key populations, such as men who have sex with men (MSM), are at higher risk of these STIs at genital and extragenital sites and these STIs are often asymptomatic, especially in extragenital sites and in women. We will conduct a clinical-based evaluation to assess the performance characteristics and acceptability to end-users of molecular-based diagnostic technology for POC/near patient use of the Xpert CT/NG (Cepheid, Sunnyvale, California, USA) test for screening of genital, anorectal and pharyngeal CT and NG infections in MSM and the Xpert CT/NG and Xpert TV (Cepheid, Sunnyvale, California, USA) for screening of genital CT, NG and TV among women at risk for these STIs compared with gold-standard reference nucleic acid amplification tests. This master protocol outlines the overall research approach that will be used in seven countries., Method and Analyses: Consecutive MSM and women at risk presenting at the clinical sites in high, and low- and middle-income countries will be enrolled. The POCTs to be evaluated are Xpert CT/NG and Xpert TV. All procedures will be carried out by trained healthcare staff and tests performed in strict accordance with the manufacturer's instructions. The sensitivity, specificity, positive and negative predictive values for each POCT will be calculated. The study is ongoing with recruitment expected to be completed in all countries by mid-2022 to late-2022., Ethics and Dissemination: Prior to enrolment, this core protocol was independently peer-reviewed and approved by the research project review panel (RP2) of the WHO Department of Sexual and Reproductive Health and Research and by the WHO Ethics Review Committee (ERC). The core protocol has been slightly adapted accordingly to individual countries and adaptations approved by both RP2 and ERC, as well as all relevant institutional review boards at each participating site. Results will be disseminated through peer-reviewed journals and presented at relevant national/international conferences., Competing Interests: Competing interests: The POCT manufacturer discloses and furnishes free of charge to WHO the information and sufficient quantities of the product(s) in order to enable this evaluation as part of the WHO/RHR STI POC initiative. WHO is entitled to evaluate and publish the trial results, and to exclusively control this evaluation and the content of the aforesaid publication. WHO shall submit any proposed publication to the POCT manufacturer for review, comments received will be considered in good faith, but the decision to publish rests with WHO., (© World Health Organization 2024. Licensee BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
28. Investigating possibilities for surveillance of long term chlamydia complications in the Netherlands: A qualitative study.
- Author
-
den Boogert EM, van Aar F, and Heijne JCM
- Subjects
- Humans, Netherlands epidemiology, Female, Male, Qualitative Research, Pregnancy, Pregnancy, Ectopic diagnosis, Pregnancy, Ectopic epidemiology, Pregnancy, Ectopic microbiology, Adult, Middle Aged, Chlamydia Infections diagnosis, Chlamydia Infections epidemiology, Chlamydia Infections microbiology, Pelvic Inflammatory Disease microbiology, Pelvic Inflammatory Disease epidemiology, Pelvic Inflammatory Disease diagnosis, Chlamydia trachomatis isolation & purification
- Abstract
Objectives: Chlamydia trachomatis (chlamydia) is one of the most reported bacterial sexually transmitted infections (STI) worldwide. Chlamydia can cause long term complications such as pelvic inflammatory disease (PID), ectopic pregnancy (EP) and tubal factor infertility (TFI). Changing testing strategies, for example reduced asymptomatic testing, influence chlamydia surveillance, highlighting the need for exploring alternative ways of monitoring chlamydia. We investigated the possibility of introducing routine surveillance of chlamydia related long term complications., Methods: A qualitative study including 15 in-depth interviews with a purposive sample of gynaecologists, general practitioners (GP), sexual health and emergency doctors was conducted in the Netherlands in 2021-2022. A semi-structured interview guide focused on experiences with diagnosis and registration of PID, EP and TFI and how a change in asymptomatic chlamydia testing strategy might influence this. Interviews were transcribed and analysed using a thematic approach., Results: Analysis showed that gynaecologists most frequently reported diagnosing PID, EP and TFI. Other professions rarely diagnose these complications, with emergency doctors only diagnosing EP. Most respondents reported unique registration codes for PID and EP, but the coding for TFI is more ambiguous. They reflected that diagnosis and registration of PID, EP and TFI are handled differently within their professions. Most respondents acknowledged registration in diagnostic codes as a useful surveillance tool. They expressed concerns in representativeness (e.g. differences in interpretation of diagnosis criteria) and data quality for surveillance., Conclusions: Patient files of gynaecologists are likely to be most complete for monitoring trends of diagnosed chlamydia related long term complications in the Netherlands. However, when establishing a chlamydia complication surveillance system, professionals should be engaged in further standardizing diagnosis and registration practices. This will improve the quality and interpretability of complication surveillance and facilitate comparison between countries., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Boogert et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
29. Inequalities in sexual and reproductive outcomes among women aged 16-24 in England (2012-2019).
- Author
-
Solomon D, Gibbs J, Burns F, Mohammed H, Migchelsen SJ, and Sabin CA
- Subjects
- Humans, Female, England epidemiology, Adolescent, Young Adult, Pregnancy, Abortion, Induced statistics & numerical data, Health Status Disparities, Socioeconomic Factors, Healthcare Disparities, Gonorrhea epidemiology, Chlamydia Infections epidemiology, Chlamydia Infections diagnosis
- Abstract
Background: Women aged 16-24 in England have a high burden of sexual and reproductive morbidity, with particularly poor outcomes among people living in more deprived areas (including racially minoritised populations). This analysis used national data to examine the disparities within sexual and reproductive outcomes among this population and to assess whether the patterns of inequality were consistent across all outcomes., Methods: Within this ecological study, univariable and multivariable Poisson regression analyses of neighbourhood-level data from national data sets were carried out to investigate the relationships of deprivation and ethnicity with each of six dependent variables: gonorrhoea and chlamydia testing rates, gonorrhoea and chlamydia test positivity rates, and abortion and repeat abortion rates., Results: When comparing Index of Multiple Deprivation (IMD) decile 1 (most deprived) and IMD decile 10 (least deprived), chlamydia (RR 0.65) and gonorrhoea (0.79) testing rates, chlamydia (0.70) and gonorrhoea (0.34) positivity rates, abortion rates (0.45) and repeat abortion rates (0.72) were consistently lower in IMD decile 10 (least deprived). Similarly, chlamydia (RR 1.24) and gonorrhoea positivity rates (1.92) and repeat abortion rates (1.31) were higher among black women than white women. Results were similar when both ethnicity and deprivation were incorporated into multivariable analyses., Conclusion: We found similar patterns of outcome inequality across a range of sexual and reproductive outcomes, despite multiple differences in the drivers of each outcome. Our analysis suggests that there are broad structural causes of inequality across sexual and reproductive health that particularly impact the health of deprived and black populations., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
30. [Guidelines for the Diagnosis and Treatment of Uncomplicated (Non-Lymphogranuloma Venereum) Chlamydia trachomatis Infection in Portugal].
- Subjects
- Humans, Portugal, Chlamydia trachomatis, Chlamydia Infections diagnosis, Chlamydia Infections drug therapy
- Abstract
Chlamydia trachomatis infection is the most prevalent sexually transmitted bacterial infection in the world. Being associated with a large number of asymptomatic carriers, the diagnosis is frequently challenging and requires appropriate laboratory testing. In Portugal, the incidence of the disease has been consistently increasing in recent years, meaning that special awareness is required for case identification, contact tracing and application of appropriate treatments. These recommendations result from the adaptation of the international consensuses on the diagnosis and treatment of Chlamydia trachomatis infection to the Portuguese healthcare setting, with the aim of standardizing the clinical and laboratory approach to symptomatic and nonsymptomatic carriers of the disease.
- Published
- 2024
- Full Text
- View/download PDF
31. Clinical Updates in Sexually Transmitted Infections, 2024.
- Author
-
Hufstetler K, Llata E, Miele K, and Quilter LAS
- Subjects
- Humans, Female, Pregnancy, United States epidemiology, Syphilis diagnosis, Syphilis epidemiology, Pregnancy Complications, Infectious diagnosis, Pregnancy Complications, Infectious epidemiology, Mass Screening, Chlamydia Infections diagnosis, Chlamydia Infections epidemiology, Gonorrhea diagnosis, Gonorrhea epidemiology, Practice Guidelines as Topic, Adult, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases epidemiology
- Abstract
Sexually transmitted infections (STIs) continue to increase in the United States with more than 2.5 million cases of gonorrhea, chlamydia, and syphilis reported to the Centers for Disease Control and Prevention in 2022. Untreated STIs in women can lead to adverse outcomes, including pelvic inflammatory disease, infertility, chronic pelvic pain, and pregnancy complications such as ectopic pregnancy, early pregnancy loss, stillbirth, and neonatal transmission. STI-related guidelines can be complex and are frequently updated, making it challenging to stay informed on current guidance. This article provides high-yield updates to support clinicians managing STIs by highlighting changes in screening, diagnosis, and treatment. One important topic includes new guidance on syphilis screening, including a clarified description of high community rates of syphilis based on Healthy People 2030 goals, defined as a case rate of primary or secondary syphilis > 4.6 per 100,000. Reproductive aged persons living in counties above this threshold should be offered syphilis screening. Additionally, American College of Obstetricians & Gynecologists now recommends syphilis screening three times during pregnancy regardless of risk-at the first prenatal visit, during the third trimester, and at delivery. In addition, new guidance to support consideration for extragenital screening for gonorrhea and chlamydia in women at sites such as the anus and pharynx is discussed. Other topics include the most recent chlamydia, gonorrhea, trichomoniasis, and pelvic inflammatory disease treatment recommendations; screening and treatment guidance for Mycoplasma genitalium ; genital herpes screening indications and current diagnostic challenges; and the diagnosis and management of mpox in women and during pregnancy.
- Published
- 2024
- Full Text
- View/download PDF
32. Using Self-Reported Sexual Positioning as an Indicator for Rectal Chlamydia and Gonorrhea Screening Among Men Who Have Sex With Men in China: A Missed Opportunity.
- Author
-
Weng RX, Ning N, Luo YT, Zhang CL, Wen LZ, Ye JB, Li J, Chen XS, and Cai YM
- Subjects
- Humans, Male, China epidemiology, Cross-Sectional Studies, Adult, Mass Screening, Rectum microbiology, Young Adult, Risk Factors, Rectal Diseases microbiology, Rectal Diseases diagnosis, Rectal Diseases epidemiology, Sexual and Gender Minorities, Middle Aged, Reproducibility of Results, Gonorrhea diagnosis, Gonorrhea epidemiology, Chlamydia Infections diagnosis, Chlamydia Infections epidemiology, Homosexuality, Male, Self Report, Sexual Behavior, Neisseria gonorrhoeae isolation & purification, Chlamydia trachomatis isolation & purification
- Abstract
Background: Rectal Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections among men who have sex with men (MSM) are escalating public health concerns. This study aimed to explore (1) the reliability of self-reported sexual positioning as an indicator for rectal CT and NG screening, and (2) factors associated with rectal CT and NG infections in Shenzhen, China., Methods: A cross-sectional study was conducted in 2 settings in Shenzhen, China, from April 1, 2021, to March 31, 2022. Data on sociodemographic characteristics, sexual behaviors, and basic CT knowledge were collected. Urine and self-collected rectal swabs were collected for CT and NG testing., Results: In total, 195 MSM participated in the study, and 5.1% tested positive for urogenital CT, 29.2% for rectal CT, 1.0% for urogenital NG, and 8.2% for rectal NG. Among those who reported exclusively insertive anal sex, 69.2% of CT infections and 85.7% of NG infections would have remained undetected with urine testing alone. Risk factors for rectal CT infection included engaging in both insertive and receptive anal sex, with a significant association found for coinfection with rectal NG., Conclusions: Self-reported sexual positioning was found to be an unreliable indicator for CT and NG screening, as a substantial proportion of infections would have remained undetected. The findings suggest that CT and NG screening in China should be offered to all MSM regardless of self-reported sexual positioning, and that the dual CT/NG testing is recommended., Competing Interests: Conflict of Interest and Sources of Funding: The authors declare no conflict of interest. This study was supported by the Sanming Project of Medicine in Shenzhen (No. SZSM201611077)., (Copyright © 2024 American Sexually Transmitted Diseases Association. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
33. Comparative performance of vulvovaginal swab sampling versus endocervical sampling for the detection of Chlamydia, Gonorrhea, Mycoplasma genitalium, and Trichomoniasis: a cross-sectional study in Spain.
- Author
-
Linares M, Galicia P, Rojas A, Miguel-Benito A, Cuadros-González J, and Ramos-Rincón JM
- Subjects
- Humans, Female, Cross-Sectional Studies, Retrospective Studies, Adult, Spain, Young Adult, Mycoplasma Infections diagnosis, Sensitivity and Specificity, Cervix Uteri microbiology, Cervix Uteri pathology, Vaginal Smears, Vagina microbiology, Middle Aged, Trichomonas Infections diagnosis, Adolescent, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases microbiology, Gonorrhea diagnosis, Chlamydia Infections diagnosis, Mycoplasma genitalium isolation & purification, Specimen Handling methods
- Abstract
Introduction: The global increase in sexual transmitted infections (STI) makes it necessary to seek public health strategies that facilitate rapid and minimally invasive diagnosis. The objective was to evaluate the concordance between vaginal and endocervical samples for STI diagnosis., Materials and Methods: A retrospective cross-sectional study was carried out on vaginal and endocervical samples from women attended in our reference area with symptoms suggestive of vulvovaginitis or for STI screening during the study period., Results: A total of 130 paired samples were analyzed; fifty-seven and 59 samples were positive for vaginal and endocervical specimens (Kappa index of 0.969 (Standard error = 0.022). The sensitivity of the vaginal samples was 96.5% (IC95%: 87.2-99.4), with a specificity of 100% (IC95%: 93.0-100)., Discussion: The introduction of STI screening in vaginal samples in our environment can facilitate rapid and effective diagnosis and allow early treatment of STI. Additionally, it facilitates sample collection and diagnosis in the community setting, essential for optimal screening., (Copyright © 2024 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
34. Relative Cost and Infectious Days Averted Associated With Rapid Gonorrhea and Chlamydia Testing Among Men Who Have Sex With Men.
- Author
-
Welford E, Martin TCS, Martin NK, Tilghman W, and Little SJ
- Subjects
- Humans, Male, Adult, California epidemiology, Cost-Benefit Analysis, Prospective Studies, Female, Point-of-Care Testing economics, Transgender Persons, Gonorrhea diagnosis, Gonorrhea economics, Chlamydia Infections diagnosis, Chlamydia Infections economics, Nucleic Acid Amplification Techniques economics, Neisseria gonorrhoeae isolation & purification, Chlamydia trachomatis isolation & purification, Homosexuality, Male
- Abstract
Background: Standard-of-care nucleic acid amplification tests (routine NAATs) for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT) can take several days to result and therefore delay treatment. Rapid point-of-care GC/CT NAAT (rapid NAAT) could reduce the time to treatment and therefore onward transmission. This study evaluated the incremental cost per infectious day averted and overall cost of implementation associated with rapid compared with routine NAAT., Methods: Prospective sexually transmitted infection (STI) treatment data from men who have sex with men and transgender women in San Diego who received rapid NAAT between November 2018 and February 2021 were evaluated. Historical time from testing to treatment for routine NAAT was abstracted from the literature. Costs per test for rapid and routine NAAT were calculated using a micro-costing approach. The incremental cost per infectious day averted comparing rapid to routine NAAT and the costs of rapid GC/CT NAAT implementation in San Diego Public Health STI clinics were calculated., Results: Overall, 2333 individuals underwent rapid NAAT with a median time from sample collection to treatment of 2 days compared with 7 to 14 days for routine NAAT equating to a reduction of 5 to 12 days. The cost of rapid and routine GC/CT NAAT was $57.86 and $18.38 per test, respectively, with a cost-effectiveness of between $2.43 and $5.82 per infectious day averted. The incremental cost of rapid NAAT improved when at least 2000 tests were performed annually., Conclusions: Although rapid GC/CT NAAT is more expensive than routine testing, the reduction of infectious days between testing and treatment may reduce transmission and provide improved STI treatment services to patients., Competing Interests: Conflict of Interest and Sources of Funding: S.J.L. has received funding from Gilead Sciences paid to her institution and donation of medications from Gilead Sciences. E.W., T.C.S.M., N.K.M., and W.T. have no conflicts of interest to disclose., (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Sexually Transmitted Diseases Association.)
- Published
- 2024
- Full Text
- View/download PDF
35. Effectiveness of Incentivized Peer Referral to Increase Enrollment in a Community-Based Chlamydia Screening and Treatment Study Among Young Black Men.
- Author
-
Campbell MB, Ratnayake A, Gomes G, Stoecker C, and Kissinger PJ
- Subjects
- Adolescent, Adult, Humans, Male, Young Adult, Community Health Services, COVID-19 ethnology, Motivation, New Orleans epidemiology, Black or African American statistics & numerical data, Chlamydia Infections ethnology, Chlamydia Infections diagnosis, Chlamydia Infections prevention & control, Mass Screening statistics & numerical data, Peer Group, Referral and Consultation statistics & numerical data
- Abstract
Objectives: Young Black men are under-represented in sexual health services and research, a condition likely magnified during COVID-19 shutdowns due to disruption of STI screening and treatment services. We examined the effect of incentivized peer referral (IPR) increasing peer referral among young Black men in a community-based chlamydia screening program., Methods: Young Black men in New Orleans, LA, age 15-26 years enrolled in a chlamydia screening program between 3/2018 and 5/2021 were included. Enrollees were provided with recruitment materials to distribute to peers. Starting July 28, 2020, enrollees were also offered a $5 incentive for each peer enrolled. Enrollment was compared before and after the incentivize peer referral program (IPR) was implemented using multiple time series analysis (MTSA)., Results: The percentage of men referred by a peer was higher during IPR compared to pre-IPR (45.7% vs. 19.7%, p < 0.001). After the COVID-19 shutdown was lifted, there were 2.007 more recruitments per week (p = 0.044, 95% CI (0.0515, 3.964)) for IPR, compared to pre-IPR. Overall, there was a trending increase in recruitments in the IPR era relative to the pre-IPR era (0.0174 recruitments/week, p = 0.285, 95% CI (- 0.0146, 0.0493)) with less recruitment decay during IPR compared to pre-IPR., Conclusions: IPR may be an effective means of engaging young Black men in community-based STI research and prevention programs, particularly when clinic access is limited., Clinical Trials Registry Site and Number: Clinicaltrials.gov identifier NCT03098329., (© 2023. W. Montague Cobb-NMA Health Institute.)
- Published
- 2024
- Full Text
- View/download PDF
36. At-Home Diagnostics Solutions for Chlamydia and Gonorrhea.
- Author
-
Kersh EN and Mena LA
- Subjects
- Female, Humans, Male, Chlamydia trachomatis isolation & purification, Health Services Accessibility, Neisseria gonorrhoeae isolation & purification, United States, United States Food and Drug Administration, Chlamydia Infections diagnosis, Gonorrhea diagnosis, Self-Testing
- Published
- 2024
- Full Text
- View/download PDF
37. Testing for extragenital Neisseria gonorrhoeae and Chlamydia trachomatis: At-home pharyngeal and rectal self-swabs are non-inferior to those completed in healthcare settings.
- Author
-
Orser L, Tran V, O'Byrne P, Kroch A, Bonnetsmueller M, Hasso M, and Musten A
- Subjects
- Humans, Male, Adult, Female, Nucleic Acid Amplification Techniques methods, Homosexuality, Male, Middle Aged, Self Care, Young Adult, Chlamydia trachomatis isolation & purification, Chlamydia trachomatis genetics, Chlamydia Infections diagnosis, Chlamydia Infections microbiology, Gonorrhea diagnosis, Gonorrhea microbiology, Neisseria gonorrhoeae isolation & purification, Neisseria gonorrhoeae genetics, Rectum microbiology, Pharynx microbiology, Specimen Handling methods
- Abstract
Introduction: The rates of gonorrhea and chlamydia have been increasing in the years preceding the COVID19 pandemic. Because most gonorrhea and chlamydia infections are located in the oropharynx and rectum for men who have sex with men (MSM), and because at-home self-collected swabs for these infections are not licensed by Health Canada or the United States Food and Drug Administration, decreased accessed to in-person care during and since the COVID19 pandemic potentially means missed case findings., Objectives: To evaluate the performance of at-home self-collected pharyngeal and rectal swabs for gonorrhea and chlamydia nucleic acid amplification testing., Methodology: All persons who contacted our Sexual Health Clinic and who had a clinical indication to complete oral and/or rectal swabs for gonorrhea and chlamydia were invited to complete at-home swabs in advance of their scheduled appointments. We mailed swabs and instructions to those who consented. Participants brought these swabs to their scheduled in clinic appointments, where we repeated the same swabs. All matching swabs were sent to the laboratory for analysis to determine concordance., Results: From September 8, 2022 to July 18, 2023, we enrolled 296 eligible participants who provided 1184 swabs. For analysis, cancelled specimens and specimens with invalid results were excluded, leaving 1032 swabs for comparison. We identified 66 STI diagnoses in 47 unique participants. Overall accuracy was high (exceeding 99%), except for rectal chlamydia, which was 96.0%. While the performance of self-swabs for chlamydia was lower compared to gonorrhea, at-home swabs identified six chlamydia infections that were missed by in-clinic collected swabs (two pharyngeal, four rectal). Removing these six cases as "false positives" increased overall accuracy for chlamydia detection to 99.7% (pharyngeal) and 97.8% (rectal)., Conclusion: Self-collected at-home swabs had good performance acceptable for gonorrhea and chlamydia nucleic acid amplification testing., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Orser et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
38. Aetiology of vaginal discharge, urethral discharge, and genital ulcer in sub-Saharan Africa: A systematic review and meta-regression.
- Author
-
Michalow J, Walters MK, Edun O, Wybrant M, Davies B, Kufa T, Mathega T, Chabata ST, Cowan FM, Cori A, Boily MC, and Imai-Eaton JW
- Subjects
- Humans, Africa South of the Sahara epidemiology, Female, Sexually Transmitted Diseases epidemiology, Sexually Transmitted Diseases diagnosis, Vaginosis, Bacterial epidemiology, Vaginosis, Bacterial diagnosis, Vaginosis, Bacterial complications, Chlamydia Infections epidemiology, Chlamydia Infections complications, Chlamydia Infections diagnosis, Urethral Diseases epidemiology, Urethral Diseases etiology, Genital Diseases, Female epidemiology, Vaginal Discharge epidemiology, Vaginal Discharge etiology, Ulcer epidemiology
- Abstract
Background: Syndromic management is widely used to treat symptomatic sexually transmitted infections in settings without aetiologic diagnostics. However, underlying aetiologies and consequent treatment suitability are uncertain without regular assessment. This systematic review estimated the distribution, trends, and determinants of aetiologies for vaginal discharge, urethral discharge, and genital ulcer in sub-Saharan Africa (SSA)., Methods and Findings: We searched Embase, MEDLINE, Global Health, Web of Science, and grey literature from inception until December 20, 2023, for observational studies reporting aetiologic diagnoses among symptomatic populations in SSA. We adjusted observations for diagnostic test performance, used generalised linear mixed-effects meta-regressions to generate estimates, and critically appraised studies using an adapted Joanna Briggs Institute checklist. Of 4,418 identified records, 206 reports were included from 190 studies in 32 countries conducted between 1969 and 2022. In 2015, estimated primary aetiologies for vaginal discharge were candidiasis (69.4% [95% confidence interval (CI): 44.3% to 86.6%], n = 50), bacterial vaginosis (50.0% [95% CI: 32.3% to 67.8%], n = 39), chlamydia (16.2% [95% CI: 8.6% to 28.5%], n = 50), and trichomoniasis (12.9% [95% CI: 7.7% to 20.7%], n = 80); for urethral discharge were gonorrhoea (77.1% [95% CI: 68.1% to 84.1%], n = 68) and chlamydia (21.9% [95% CI: 15.4% to 30.3%], n = 48); and for genital ulcer were herpes simplex virus type 2 (HSV-2) (48.3% [95% CI: 32.9% to 64.1%], n = 47) and syphilis (9.3% [95% CI: 6.4% to 13.4%], n = 117). Temporal variation was substantial, particularly for genital ulcer where HSV-2 replaced chancroid as the primary cause. Aetiologic distributions for each symptom were largely the same across regions and population strata, despite HIV status and age being significantly associated with several infection diagnoses. Limitations of the review include the absence of studies in 16 of 48 SSA countries, substantial heterogeneity in study observations, and impeded assessment of this variability due to incomplete or inconsistent reporting across studies., Conclusions: In our study, syndrome aetiologies in SSA aligned with World Health Organization guidelines without strong evidence of geographic or demographic variation, supporting broad guideline applicability. Temporal changes underscore the importance of regular aetiologic re-assessment for effective syndromic management., Prospero Number: CRD42022348045., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Michalow et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
39. Chlamydial and Gonococcal Infections and Adverse Reproductive Health Conditions Among Patients Assigned Female at Birth in the Veterans Health Administration.
- Author
-
Gardella CM, Borgerding J, Maier MM, and Beste LA
- Subjects
- Pregnancy, Infant, Newborn, Humans, Female, Retrospective Studies, Reproductive Health, Veterans Health, Chlamydia trachomatis, Pelvic Pain complications, Gonorrhea diagnosis, Pelvic Inflammatory Disease epidemiology, Pelvic Inflammatory Disease etiology, Chlamydia Infections complications, Chlamydia Infections epidemiology, Chlamydia Infections diagnosis, Pregnancy, Ectopic epidemiology, Infertility
- Abstract
Background: Reproductive age female individuals comprise the fastest-growing segment of Veterans Health Administration patients, but little is known about rates of reproductive health outcomes among those with chlamydia or gonorrhea infections. Our aim was to estimate the risk of pelvic inflammatory disease, ectopic pregnancy, infertility, and pelvic pain in female veterans tested for chlamydia or gonorrhea., Methods: We performed a retrospective cohort analysis of female veterans tested for chlamydia or gonorrhea between January 1, 2010, and December 31, 2020. We calculated rates of pelvic inflammatory disease, ectopic pregnancy, infertility, and pelvic pain per 100,000 person-years and used Cox proportional hazards regression models to estimate the risk of these reproductive health conditions according to infection status after adjustment for age, race, ethnicity, military sexual trauma, mental health diagnoses, and substance use disorder., Results: Of female veterans, 232,614 were tested at least once for chlamydia or gonorrhea, with a total of 1,665,786 person-years of follow-up. Of these, 12,971 had positive chlamydia or gonorrhea results (5.8%, 796 cases per 100,000 person-years). Compared with people who tested negative, those testing positive had double the risk of pelvic inflammatory disease (adjusted hazard ratio [aHR], 1.94; 95% confidence interval [CI], 1.81-2.07), 11% increased risk of infertility (aHR, 1.11; 95% CI, 1.04-1.18), 12% increased risk of pelvic pain (aHR, 1.12; 95% CI, 1.08-1.17), and 21% increased risk of any of these conditions (aHR, 1.21; 95% CI, 1.17-1.25). People with positive chlamydia or gonorrhea testing tended to have an increased risk of ectopic pregnancy (aHR, 1.14; 95% CI, 1.0-1.30). Among those with a positive test result, 2218 people (17.1%) had 1 or more additional positive test results. Compared with those with 1 positive test result, people with more than 1 positive test result had a significantly increased risk of pelvic inflammatory disease (aHR, 1.37; 95% CI, 1.18-1.58), infertility (aHR, 1.20; 95% CI, 1.04-1.39), and pelvic pain (aHR1.16; 95% CI, 1.05-1.28), but not ectopic pregnancy (aHR, 1.09; 95% CI, 0.80-1.47)., Conclusions: Female veterans with positive chlamydia or gonorrhea results experience a significantly higher risk of pelvic inflammatory disease, infertility, and pelvic pain, especially among those with repeat infection., Competing Interests: Conflict of interest and Sources of Funding: None declared., (Copyright © 2024 American Sexually Transmitted Diseases Association. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
40. Sexually Transmitted Infection Co-testing in a Large Urban Emergency Department.
- Author
-
Ford JS, Morrison JC, Wagner JL, Nangia D, Voong S, Matsumoto CG, Chechi T, Tran N, and May L
- Subjects
- Humans, Cross-Sectional Studies, Female, Retrospective Studies, Adult, Male, Prevalence, Middle Aged, Chlamydia Infections diagnosis, Chlamydia Infections epidemiology, Adolescent, Young Adult, Emergency Service, Hospital, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases epidemiology, Coinfection epidemiology, Coinfection diagnosis, Gonorrhea diagnosis, Gonorrhea epidemiology, Syphilis diagnosis, Syphilis epidemiology, Hepatitis C epidemiology, Hepatitis C diagnosis, Mass Screening methods, HIV Infections epidemiology, HIV Infections diagnosis
- Abstract
Introduction: The incidence of sexually transmitted infections (STI) increased in the United States between 2017-2021. There is limited data describing STI co-testing practices and the prevalence of STI co-infections in emergency departments (ED). In this study, we aimed to describe the prevalence of co-testing and co-infection of HIV, hepatitis C virus (HCV), syphilis, gonorrhea, and chlamydia, in a large, academic ED., Methods: This was a single-center, retrospective cross-sectional study of ED patients tested for HIV, HCV, syphilis, gonorrhea or chlamydia between November 27, 2018-May 26, 2019. In 2018, the study institution implemented an ED-based infectious diseases screening program in which any patient being tested for gonorrhea/chlamydia was eligible for opt-out syphilis screening, and any patient 18-64 years who was having blood drawn for any clinical purpose was eligible for opt-out HIV and HCV screening. We analyzed data from all ED patients ≥13 years who had undergone STI testing. The outcomes of interest included prevalence of STI testing/co-testing and the prevalence of STI infection/co-infection. We describe data with simple descriptive statistics., Results: During the study period there were 30,767 ED encounters for patients ≥13 years (mean age: 43 ± 14 years, 52% female), and 7,866 (26%) were tested for at least one of HIV, HCV, syphilis, gonorrhea, or chlamydia. We observed the following testing frequencies (and prevalence of infection): HCV, 7,539 (5.0%); HIV, 7,359 (0.9%); gonorrhea, 574 (6.1%); chlamydia, 574 (9.8%); and syphilis, 420 (10.5%). Infectious etiologies with universal testing protocols (HIV and HCV) made up the majority of STI testing. In patients with syphilis, co-infection with chlamydia (21%, 9/44) and HIV (9%, 4/44) was high. In patients with gonorrhea, co-infection with chlamydia (23%, 8/35) and syphilis (9%, 3/35) was high, and in patients with chlamydia, co-infection with syphilis (16%, 9/56) and gonorrhea (14%, 8/56) was high. Patients with HCV had low co-infection proportions (<2%)., Conclusion: Prevalence of STI co-testing was low among patients with clinical suspicion for STIs; however, co-infection prevalence was high in several co-infection pairings. Future efforts are needed to improve STI co-testing rates among high-risk individuals., Competing Interests: Conflicts of Interest: By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. This work was supported by Gilead-funded Frontlines of Communities in the United States (FOCUS). The FOCUS Program is a public health initiative that enables partners to develop and share best practices in routine blood-borne virus (HIV, HCV, HBV) screening, diagnosis, and linkage to care in accordance with screening guidelines promulgated by the US Centers for Disease Control and Prevention, the US Preventive Services Task Force (USPSTF), and state and local public health departments. FOCUS funding supports HIV, HCV, and HBV screening and linkage to the first medical appointment after diagnosis. FOCUS partners do not use FOCUS awards for activities beyond linkage to the first medical appointment. There are no other conflicts of interest or sources of funding to declare.
- Published
- 2024
- Full Text
- View/download PDF
41. Reducing Barriers for Expedited Partner Treatment in Adolescents and Young Adults: A Quality Improvement Initiative.
- Author
-
Richards MJ, Bogart A, and Sheeder J
- Subjects
- Child, Humans, Young Adult, Adolescent, Quality Improvement, Sexual Partners psychology, Chlamydia trachomatis, Contact Tracing, Chlamydia Infections diagnosis, Chlamydia Infections drug therapy, Chlamydia Infections epidemiology, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases drug therapy, Sexually Transmitted Diseases epidemiology, Trichomonas vaginalis, Trichomonas Infections diagnosis, Trichomonas Infections drug therapy, Trichomonas Infections epidemiology
- Abstract
Background: Adolescents and young adults (AYAs) face significant barriers to screening, testing, and treatment of sexually transmitted infections (STIs). Expedited partner therapy (EPT) streamlines partner treatment of STIs, but use among adolescents is low. We aimed to increase EPT offering and provision at 2 adolescent medicine clinics (AMCs) and the emergency department (ED) in an urban children's hospital. We addressed barriers at provider, pharmacy, and patient levels. We compared EPT offering and provision for chlamydia ( Chlamydia trachomatis [CT]) and trichomonas ( Trichomonas vaginalis [TV]) infection at baseline and across 2 intervention cycles., Methods: Baseline data were collected from July 2019 to March 2020 and our intervention time frame spanned from April 2020 to October 2021. Laboratory codes identified patients with CT or TV infections. Cycle 1 allowed providers to order EPT within a patient's chart. The second cycle targeted education and standardization for STI/EPT notification and counseling. During this cycle, notification of ED patients was centralized to the AMC nurses., Results: A total of 747 CT and TV cases were identified. In the AMC, EPT offering increased from 77.3% to 87.7% ( P = 0.01). Expedited partner therapy provision increased from 32.3% to 69.9% ( P < 0.001). Expedited partner therapy offering for ED patients increased by 82.3%. Retesting rates remained consistent, with a significant drop in reinfection rates ( P = 0.003) within patients seen in the AMC., Conclusions: This quality improvement initiative successfully increased EPT offering and provision among the cases identified. Future cycles may include longer-term follow-up to confirm partner treatment and testing per guidelines., Competing Interests: Conflicts of Interest and Sources of Funding: The authors have no conflicts of interest to disclose. The authors received a small grant from the Clinical, Operational Excellence, and Patient Safety (COEPS) Small Grants Program at the Children's Hospital Colorado., (Copyright © 2024 American Sexually Transmitted Diseases Association. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
42. Anorectal lymphogranuloma venereum among men who have sex with men: a 3-year nationwide survey, France, 2020 to 2022.
- Author
-
Peuchant O, Laurier-Nadalié C, Albucher L, Balcon C, Dolzy A, Hénin N, Touati A, and Bébéar C
- Subjects
- Humans, Male, France epidemiology, Adult, Female, Middle Aged, Surveys and Questionnaires, Chlamydia Infections epidemiology, Chlamydia Infections diagnosis, Young Adult, Rectum microbiology, Prevalence, Sexual and Gender Minorities statistics & numerical data, Lymphogranuloma Venereum epidemiology, Lymphogranuloma Venereum diagnosis, Chlamydia trachomatis genetics, Chlamydia trachomatis isolation & purification, Homosexuality, Male statistics & numerical data
- Abstract
BackgroundIn France, lymphogranuloma venereum (LGV) testing switched from universal to selective testing in 2016.AimTo investigate changes in LGV-affected populations, we performed a nationwide survey based on temporarily reinstated universal LGV testing from 2020 to 2022.MethodsEach year, during three consecutive months, laboratories voluntarily sent anorectal Chlamydia trachomatis -positive samples from men and women to the National Reference Centre for bacterial sexually transmitted infections. We collected patients' demographic, clinical and biological data. Genovars L of C. trachomatis were detected using real-time PCR. In LGV-positive samples, the omp A gene was sequenced.ResultsIn 2020, LGV positivity was 12.7% (146/1,147), 15.2% (138/907) in 2021 and 13.3% (151/1,137) in 2022 (p > 0.05). It occurred predominantly in men who have sex with men (MSM), with rare cases among transgender women. The proportion of HIV-negative individuals was higher than that of those living with HIV. Asymptomatic rectal LGV increased from 36.1% (44/122) in 2020 to 52.4% (66/126) in 2022 (p = 0.03). Among users of pre-exposure prophylaxis (PrEP), LGV positivity was 13.8% (49/354) in 2020, 15.6% (38/244) in 2021 and 10.9% (36/331) in 2022, and up to 50% reported no anorectal symptoms. Diversity of the LGV ompA genotypes in the Paris region increased during the survey period. An unexpectedly high number of ompA genotype L1 variant was reported in 2022.ConclusionIn rectal samples from MSM in France, LGV positivity was stable, but the proportion of asymptomatic cases increased in 2022. This underscores the need of universal LGV testing and the importance of continuous surveillance.
- Published
- 2024
- Full Text
- View/download PDF
43. Use of Expedited Partner Therapy for Pregnant Women Treated for Sexually Transmitted Infections in Gaborone, Botswana.
- Author
-
Hansman E, Mussa A, Ryan R, Babalola CM, Ramontshonyana K, Tamuthiba L, Ndlovu N, Bame B, Klausner JD, Morroni C, and Wynn A
- Subjects
- Female, Humans, Pregnancy, Botswana epidemiology, Chlamydia trachomatis, Contact Tracing, Pregnant Women, Sexual Partners, Chlamydia Infections diagnosis, Chlamydia Infections drug therapy, Chlamydia Infections epidemiology, Gonorrhea diagnosis, Gonorrhea drug therapy, Gonorrhea epidemiology, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases drug therapy, Sexually Transmitted Diseases epidemiology
- Abstract
Background: Partner notification and treatment for sexually transmitted infections are critical to prevent reinfection and reduce transmission. However, partner treatment rates are low globally. Expedited partner therapy (EPT), in which the patient delivers treatment directly to their partner, may result in more partners treated. We assessed partner notification and treatment outcomes among pregnant women in Gaborone, Botswana, including EPT intent, uptake, and effectiveness., Methods: The Maduo study was a cluster-controlled trial evaluating the effect of antenatal Chlamydia trachomatis and Neisseria gonorrhoeae infection screening in pregnant women. The intervention arm received screening at first antenatal care (ANC), third-trimester, and postnatal care visits. The standard-of-care arm received screening postnatally. Participants screening positive were given options for partner treatment: contact slips, in-clinic treatment, or EPT. Self-reported partner notification and treatment outcomes were assessed at test-of-cure visit., Results: Of 51 women who screened positive for C. trachomatis / N. gonorrhoeae at first ANC and returned for test of cure, 100% reported notifying their partner and 48 (94.1%) reported their partner received treatment. At third trimester 100% (n = 5), reported partners were treated. Before testing, EPT intent was lower than EPT uptake at all time points (first ANC: 17.9% vs. 80.4%; third-trimester: 57.1% vs. 71.4%; postnatal care: 0% vs. 80.0%). Partner treatment success was 100% among EPT users compared with 70% among nonusers ( P = 0.006)., Conclusions: Partner notification and treatment success was high in this population. Despite low pretest intent to use EPT, uptake was high and associated with greater partner treatment success. Our findings suggest that EPT may be a successful partner treatment strategy to pursue in low- and middle-income countries., Competing Interests: Conflict of Interest and Sources of Funding: The authors have no competing interests to disclose., (Copyright © 2024 American Sexually Transmitted Diseases Association. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
44. Association Between Sexually Transmitted Infections and the Urine Culture.
- Author
-
Sheele JM, Mead-Harvey C, and Hodgson NR
- Subjects
- Humans, Female, Adult, Chlamydia Infections urine, Chlamydia Infections diagnosis, Middle Aged, Chlamydia trachomatis isolation & purification, Emergency Service, Hospital, Trichomonas vaginalis isolation & purification, Bacteriuria diagnosis, Bacteriuria urine, Bacteriuria microbiology, Young Adult, Neisseria gonorrhoeae isolation & purification, Urine microbiology, Retrospective Studies, Adolescent, Trichomonas Infections diagnosis, Trichomonas Infections urine, Urinary Tract Infections diagnosis, Urinary Tract Infections microbiology, Urinary Tract Infections urine, Sexually Transmitted Diseases urine, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases microbiology, Gonorrhea diagnosis, Gonorrhea urine, Urinalysis methods
- Abstract
Introduction: Bacterial urinary tract infections (UTI) and some sexually transmitted infections (STI) can have overlapping signs and symptoms or nonspecific findings, such as pyuria on urinalysis. Furthermore, results from the urine culture and the nucleic acid amplification test for an STI may not be available during the clinical encounter. We sought to determine whether gonorrhea, chlamydia, and trichomoniasis are associated with bacteriuria, information that might aid in the differentiation of STIs and UTIs., Methods: We used multinomial logistic regression to analyze 9,650 encounters of female patients who were aged ≥18 years and who underwent testing for STIs. The ED encounters took place from April 18, 2014-March 7, 2017. We used a multivariable regression analysis to account for patient demographics, urinalysis findings, vaginal wet-mount results, and positive or negative (or no) findings from the urine culture and testing for Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis., Results: In multivariable analysis, infection with T vaginalis , N gonorrhoeae, or C trachomatis was not associated with having a urine culture yielding 10,000 or more colony-forming units per mililiter (CFU/mL) of bacteria compared with a urine culture yielding less than 10,000 CFU/mL or no urine culture obtained. The diagnosis of a UTI in the ED was not associated with having a urine culture yielding 10,000 or more CFU/mL compared with a urine culture yielding less than 10,000 CFU/mL., Conclusion: After adjusting for covariates, no association was observed between urine culture results and testing positive for trichomoniasis, gonorrhea, or chlamydia. Our results suggest that having a concurrent STI and bacterial UTI is unlikely., Competing Interests: Conflicts of Interest: By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. No author has professional or financial relationships with any companies that are relevant to this study. There are no conflicts of interest or sources of funding to declare.
- Published
- 2024
- Full Text
- View/download PDF
45. Prevalence, risk factors and genotyping of chlamydia trachomatis from endocervical specimens of infertile women at a tertiary care hospital, Vietnam.
- Author
-
Nguyen H, Do Ngoc A, Nguyen Le V, Nguyen Thi NQ, Hoang Thi Y, Hoang CD, Tran Quang P, and Vu Van D
- Subjects
- Humans, Female, Vietnam epidemiology, Adult, Prevalence, Risk Factors, Young Adult, Bacterial Outer Membrane Proteins genetics, Pregnancy, Chlamydia trachomatis genetics, Chlamydia trachomatis isolation & purification, Chlamydia Infections epidemiology, Chlamydia Infections microbiology, Chlamydia Infections diagnosis, Infertility, Female microbiology, Infertility, Female epidemiology, Genotype, Cervix Uteri microbiology, Tertiary Care Centers
- Abstract
Background: To our knowledge, the prevalence, risk factors and distribution of C. trachomatis genotypes are rarely mentioned in Vietnam. This study aimed to find the prevalence, risk factors and distribution of C. trachomatis genotypes in infertile Vietnamese women., Methods: Endocervical swabs were collected from infertile women at the National Hospital of Obstetrics and Gynecology, Vietnam, between January 2020 and December 2021. All samples were analyzed for C. trachomatis presence by Cobas 4800 CT/NG Test. Sequencing methods of omp A gene were used to determine the C. trachomatis genotypes. An approximately 1200 bp omp A fragment was aligned with reference sequences from GenBank to identify the corresponding genotype., Results: The prevalence of endocervical C. trachomatis infection was 15.6% of 761 participants. Factors independently associated with CT infection among infertile women, obtained by multivariate analysis, included abnormal vaginal discharge, cervicitis, lower abdominal pain, a history of ectopic pregnancy, having more than one sex partner, and age at first intercourse. Among the samples, genotype E (25.93%) was most frequently found, followed by genotypes D/Da (22.23%), F (13.58%), G/Ga (12.35%), J (12.35%), H (6.17%), K (3.70%), B/Ba (2.47%), and I/Ia (1.23%), respectively. Genotype F was related to types of infertility, and genotype H was associated with a history of miscarriage., Conclusions: The present study indicated a high prevalence of C. trachomatis in infertile Vietnamese women. The most common genotypes found in this population were E, D, and F. Our findings suggest that routine screening is necessary for early detection and performance of infection control methods., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
46. Trends in Chlamydia trachomatis Treatment Prescribing Practices in King County, Washington, 2010-2018.
- Author
-
Brase PR, Dombrowski JC, Berzkalns A, Manhart LE, Golden MR, and Khosropour CM
- Subjects
- Female, Humans, Doxycycline therapeutic use, Anti-Bacterial Agents therapeutic use, Chlamydia trachomatis, Washington epidemiology, Azithromycin therapeutic use, Chlamydia Infections diagnosis, Chlamydia Infections drug therapy, Chlamydia Infections epidemiology
- Abstract
Background: In 2021, national Chlamydia trachomatis (CT) treatment guidelines changed from recommending either azithromycin (1 g; single dose) or doxycycline (100 mg twice daily for 7 days) to recommending only doxycycline as first-line treatment. The distribution and trends in CT prescribing practices before the guidelines change is largely unknown., Methods: We conducted a trends analysis using Washington STD surveillance data. We included all female cases of urogenital CT 15 years or older who resided in King County and were diagnosed between 2010 and 2018. Surveillance data included information on demographics, sexual history, clinical features, diagnosing facility (eg, emergency department, family planning), and treatment regimen. We conducted descriptive analyses to examine trends in prescribing practices over time and by facility type. We used Poisson regression to examine the association between CT case characteristics and receipt of receipt of azithromycin., Results: There were 36,830 cases of female urogenital CT during the study period. The percent of cases receiving azithromycin increased significantly from 86% in 2010 to 94% in 2018; the percent receiving doxycycline decreased from 13% to 5%. Five of the 8 facility types prescribed azithromycin to >95% of CT cases by 2018. Cases who were younger or cases of color were more likely to receive azithromycin (versus doxycycline) compared with older and White cases, respectively., Conclusions: A substantial shift in CT prescribing practices will be needed to adhere to new CT treatment guidelines. Our findings highlight the need for targeted provider education and training to encourage the transition to doxycycline use., Competing Interests: Conflicts of Interest: C.M.K. and M.R.G. report research support from Hologic, Inc. for studies unrelated to the submitted work. L.E.M. reports research support and donations of study materials from Hologic, Inc. and Nabriva Therapeutics for studies unrelated to the submitted work, and an honorarium from Health Advances. All other authors declare no conflicts of interest., (Copyright © 2024 American Sexually Transmitted Diseases Association. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
47. Characterization of genital chlamydia trachomatis infection among women attending infertility and gynecology clinics in Hunan, China.
- Author
-
Zhou Q, Li J, Luo L, Min S, Wang L, Peng L, Hou Y, He P, He S, Tang S, and Chen H
- Subjects
- Humans, Female, Chlamydia trachomatis genetics, Seroepidemiologic Studies, DNA, Genitalia, Infertility epidemiology, Infertility complications, Chlamydia Infections diagnosis
- Abstract
Background: Genital infection with Chlamydia trachomatis (C. trachomatis) is a major public health issue worldwide. It can lead to cervicitis, urethritis, and infertility. This study was conducted to determine the characteristics of genital C. trachomatis infection among women attending to the infertility and gynecology clinics., Methods: Endocervical swabs were collected from 8,221 women for C. trachomatis nucleotide screening and genotyping, while serum samples were collected for C. trachomatis pgp3 antibody determination using luciferase immunosorbent assays., Results: High C. trachomatis DNA prevalence (3.76%) and seroprevalence (47.46%) rates were found, with genotype E (27.5%) being the most prevalent. C. trachomatis omp1 sense mutation was associated with cervical intraepithelial neoplasia (CIN) (odds ratio [OR] = 6.033, 95% confidence interval [CI] = 1.219-39.185, p = 0.045). No significant differences in C. trachomatis seroprevalence rates were observed between women with detectable C. trachomatis DNA in the infertility and routine physical examination groups (86.67% vs. 95%, p > 0.05); however, among women with negative C. trachomatis DNA, the former group had a markedly higher seroprevalence than the latter group (56.74% vs. 20.17%, p < 0.001). C. trachomatis DNA, but not pgp3 antibody, was significantly associated with CIN (OR = 4.087, 95% CI = 2.284-7.315, p < 0.001)., Conclusion: Our results revealed a high prevalence, particularly seroprevalence, of C. trachomatis among women with infertility. Furthermore, we found an association between C. trachomatis omp1 sense mutations and CIN. Therefore, C. trachomatis serves as a risk factor for CIN., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
48. Chlamydia Proctitis.
- Author
-
Suzuki J, Hasekura S, Imai H, and Endo S
- Subjects
- Humans, Chlamydia Infections complications, Chlamydia Infections diagnosis, Chlamydia Infections drug therapy, Proctitis diagnosis, Chlamydia
- Published
- 2024
- Full Text
- View/download PDF
49. Characterization of genital chlamydia amongst female sex workers in Nairobi, Kenya.
- Author
-
Bwana P, Adungo F, Magoma G, and Mwau M
- Subjects
- Humans, Kenya epidemiology, Female, Cross-Sectional Studies, Adult, Young Adult, Surveys and Questionnaires, Adolescent, Abdominal Pain etiology, Middle Aged, Sex Workers statistics & numerical data, Chlamydia Infections diagnosis, Chlamydia Infections epidemiology, Chlamydia Infections microbiology, Chlamydia trachomatis isolation & purification, Chlamydia trachomatis genetics, Genotype
- Abstract
Introduction: genital chlamydia, which is caused by diverse Chlamydia trachomatis (C. trachomatis) genotypes, is largely asymptomatic. We aimed to identify C. trachomatis genotypes causing genital chlamydia among female sex workers attending a sex workers outreach program clinic in Nairobi, Kenya., Methods: this cross-sectional study was conducted between 18
th April 2017 and 19th March 2021. Genitourinary complaints from eligible female sex workers were documented using a structured questionnaire. Endocervical swabs were collected for laboratory analysis. C. trachomatis plasmid DNA was extracted, PCR-amplified, and sequenced. Consensus sequences were generated and aligned with reference sequences to determine the C. trachomatis genotypes. Bivariate analysis was used to determine the association between genitourinary complaints and genital chlamydia., Results: endocervical swabs were collected from a total of 348 participants. Of these, 46 (13.2%) were positive for C. trachomatis. Most (297, 85.3%) of the participants presented with pelvic discharge with or without other symptoms. Fifteen (15, 4.3%) had abdominal pain and 3 (0.9%) had an itchy vulva. There was no statistically significant relationship between clinical presentation and genital chlamydia. Twenty-three samples were successfully sequenced. Each sequence was at least 90% identical to each of the 13 references C. trachomatis genotypes A, B, C, D, E, F, G, Ia, J, L1, L2, L2b and L3., Conclusion: we found no significant association between individual genitourinary complaints and genital chlamydia infection. The C. trachomatis genotypes circulating amongst female sex workers in Nairobi could be related to genotypes A, B, C, D, E, F, G, Ia, J, L1, L2, L2b, and L3., Competing Interests: The authors declare no competing interests., (Copyright: Priska Bwana et al.)- Published
- 2024
- Full Text
- View/download PDF
50. Evaluation of a new CT/NG/TV/MG Real-Time PCR Kit (Vircell) versus the Allplex STI Essential Assay (Seegene) for the diagnosis of sexually transmitted infections.
- Author
-
Aguilera-Franco M, Tarriño-León M, Olivares-Durán MJ, Espadafor B, Rodríguez-Granger J, Reguera JA, Cobo F, Sampedro A, and Navarro JM
- Subjects
- Humans, Real-Time Polymerase Chain Reaction, Chlamydia trachomatis genetics, Neisseria gonorrhoeae genetics, Tomography, X-Ray Computed, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases epidemiology, Trichomonas vaginalis genetics, Mycoplasma genitalium genetics, Mycoplasma Infections diagnosis, Mycoplasma Infections epidemiology, Chlamydia Infections diagnosis, Gonorrhea diagnosis, Gonorrhea epidemiology
- Abstract
Sexually transmitted infections (STI) are a public health problem. Real-time PCR assays are the most sensitive test for screening and diagnosis of these infections. The aim of this study was to evaluate a new CT/NG/TV/MG Real-Time PCR (RT-PCR) kit (Vircell) for the detection of Chamydia trachomatis , Neisseria gonorrhoeae , Mycoplasma genitalium and Trichomonas vaginalis for the diagnosis of sexual transmitted infections using the Allplex STI Essential Assay (Seegene) as the reference's method. A total of 497 samples from different anatomical sites (endocervical, urethral, rectal, pharyngeal and urine) were analysed from October 2022 to February 2023. A total of 108 (21.73 %) and 106 (21.33 %) positive samples were found for any of the assays used. The most commonly detected pathogen was N. gonorrhoeae (52 samples; 10.46 %), and the least commonly detected was T. vaginalis (three samples; 0.60 %). The anatomical site with the highest prevalence of micro-organisms was a non-urogenital site, the pharynx (26 positive samples; 5.23 %). Using the Allplex STI Essential Assay (Seegene) as the reference method, the diagnosis performance showed that the average specificity of CT/NG/TV/MG RT-PCR Kit (Vircell) was 99.84 % and the sensitivity was 99.53 %. The overall concordance was k=0.98 (CI95 %; 0.96-1). In conclusion, the CT/NG/TV/MG RT-PCR Kit (Vircell) assay shows a good sensitivity and specificity and constitutes a promising and additional alternative to routine procedures for distinct types of clinical specimen in diagnosis STI.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.